<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus - Siebenhofer, A - 2006 | Cochrane Library</title> <meta property="og:title" content="Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus - Siebenhofer, A - 2006 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003287.pub4/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD003287.pub4" /> <meta name="citation_title" content="Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus" /> <meta name="citation_author" content="Andrea Siebenhofer" /> <meta name="citation_author_institution" content="Medical University Graz" /> <meta name="citation_author_email" content="andrea.siebenhofer@meduni-graz.at" /> <meta name="citation_author" content="Johannes Plank" /> <meta name="citation_author_institution" content="Medical University Graz" /> <meta name="citation_author" content="Andrea Berghold" /> <meta name="citation_author_institution" content="Medical University Graz" /> <meta name="citation_author" content="Klaus Jeitler" /> <meta name="citation_author_institution" content="Medical University Graz" /> <meta name="citation_author" content="Karl Horvath" /> <meta name="citation_author_institution" content="Medical University Graz" /> <meta name="citation_author" content="Markus Narath" /> <meta name="citation_author_institution" content="Steierm&auml;rkische Krankenanstaltengesellschaft mbH" /> <meta name="citation_author" content="Robert Gfrerer" /> <meta name="citation_author" content="Thomas R Pieber" /> <meta name="citation_author_institution" content="Medical University Graz" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="2" /> <meta name="citation_doi" content="10.1002/14651858.CD003287.pub4" /> <meta name="citation_date" content="2006" /> <meta name="citation_online_date" content="2006/04/19" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003287.pub4/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003287.pub4/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003287.pub4/pdf/CDSR/CD003287/CD003287.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Diabetes Mellitus, Type 1 [blood, *drug therapy]; Diabetes Mellitus, Type 2 [blood, *drug therapy]; Glycated Hemoglobin A [metabolism]; Hypoglycemic Agents [*therapeutic use]; Insulin [analogs &amp; derivatives, *therapeutic use]; Insulin Aspart; Insulin Lispro; Randomized Controlled Trials as Topic" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1559916431000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717784000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="y8F68iId";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003287\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003287\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","es"],languageCode:"en",accessStatus:"licensed",doi:"10.1002/14651858.CD003287.pub4",title:"Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus",firstPublishedDate:"Apr 19, 2006 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581423095000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003287.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003287.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD003287.pub4/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD003287.pub4/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003287.pub4%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD003287.PUB4" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD003287.pub4/#" data-copyright="Copyright © 2009 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <a id="read-comments-on-review" class="js-old-version-modal-trigger" data-new-version="" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/read-comments"> Read comments on this Review(1) </a> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003287.pub4/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resultados&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003287.pub4/full"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/full#CD003287-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/full#CD003287-sec1-0006"> Authors' conclusions </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/full#CD003287-sec1-0001"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/full#CD003287-sec1-0002"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/full#CD003287-sec1-0003"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/full#CD003287-sec1-0004"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/full#CD003287-sec1-0005"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/appendices#CD003287-sec1-0011"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/information#history"> History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/table_n/CD003287StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/table_n/CD003287StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD003287.PUB4"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus </h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD003287-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD003287-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD003287-bbs1-0003">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">Altuntas 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0001"> <div class="citation-journal">Altuntas Y, Ozen B, Ozturk B, Sengul A, Ucak S, Ersoy O, et al. <span class="citation-title">Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2003</span>;<span class="volume">5</span>(6):371‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+additional+metformin+or+NPH+insulin+to+mealtime+insulin+lispro+therapy+with+mealtime+human+insulin+therapy+in+secondary+OAD+failure+&author=Y+Altuntas&author=B+Ozen&author=B+Ozturk&author=A+Sengul&author=S+Ucak&author=O+Ersoy&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">Anderson 1997a {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0002"> <div class="citation-journal">Anderson JH, Brunelle RL, Keohane P, Koivisto VA, Trautmann ME, Vignati L, et al. <span class="citation-title">Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">1997</span>;<span class="volume">157</span>(11):1249‐55. [MEDLINE: 545] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9183237" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Mealtime+treatment+with+insulin+analog+improves+postprandial+hyperglycemia+and+hypoglycemia+in+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=JH+Anderson&author=RL+Brunelle&author=P+Keohane&author=VA+Koivisto&author=ME+Trautmann&author=L+Vignati&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">Anderson 1997b {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0003"> <div class="citation-journal">Anderson JH, Brunelle RL, Koivisto VA, Pfuetzner A, Trautmann ME, Vignati L, et al. <span class="citation-title">Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin‐analog treatment. Multicenter Insulin Lispro Study Group</span>. <span class="citation"> Diabetes </span><span class="pubYear">1997</span>;<span class="volume">46</span>(2):265‐70. [MEDLINE: 722] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9000704" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Reduction+of+postprandial+hyperglycemia+and+frequency+of+hypoglycemia+in+IDDM+patients+on+insulin%E2%80%90analog+treatment.+Multicenter+Insulin+Lispro+Study+Group+&author=JH+Anderson&author=RL+Brunelle&author=VA+Koivisto&author=A+Pfuetzner&author=ME+Trautmann&author=L+Vignati&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">Anderson 1997c {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0004"> <div class="citation-journal">Anderson JH, Brunelle RL, Koivisto VA, Trautmann ME, Vignati L, DiMarchi R. <span class="citation-title">Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">1997</span>;<span class="volume">19</span>(1):62‐72. [MEDLINE: 721] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9083709" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+mealtime+treatment+of+diabetes+mellitus+using+an+insulin+analogue.+Multicenter+Insulin+Lispro+Study+Group+&author=JH+Anderson&author=RL+Brunelle&author=VA+Koivisto&author=ME+Trautmann&author=L+Vignati&author=R+DiMarchi&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">Annuzzi 2001 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0005"> <div class="citation-journal">Annuzzi G, Prato S, Arcari R, Bellomo Damato A, Benzi L, Bruttomesso D, et al. <span class="citation-title">Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial</span>. <span class="citation"> Nutrition, metabolism, and cardiovascular diseases </span><span class="pubYear">2001</span>;<span class="volume">11</span>:168‐75. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Preprandial+combination+of+lispro+and+NPH+insulin+improves+overall+blood+glucose+control+in+type+1+diabetic+patients:+a+multicenter+randomized+crossover+trial+&author=G+Annuzzi&author=S+Prato&author=R+Arcari&author=A+BellomoDamato&author=L+Benzi&author=D+Bruttomesso&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">Bode 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0006"> <div class="citation-journal">Bode BW, Strange P. <span class="citation-title">Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2001</span>;<span class="volume">24</span>(1):69‐72. [MEDLINE: 106] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11194244" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy,+safety,+and+pump+compatibility+of+insulin+aspart+used+in+continuous+subcutaneous+insulin+infusion+therapy+in+patients+with+type+1+diabetes+&author=BW+Bode&author=P+Strange&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">Bode 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0007"> <div class="citation-journal">Bode B, Weinstein R, Bell D, McGill J, Nadeau D, Raskin P, et al. <span class="citation-title">Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>(3):439‐44. [MEDLINE: 1] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11874927" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+insulin+aspart+with+buffered+regular+insulin+and+insulin+lispro+in+continuous+subcutaneous+insulin+infusion+&author=B+Bode&author=R+Weinstein&author=D+Bell&author=J+McGill&author=D+Nadeau&author=P+Raskin&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">Boehm 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0008"> <div class="citation-journal">Boehm BO, Home PD, Behrend C, Kamp NM, Lindholm A. <span class="citation-title">Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in type 1 and type 2 diabetic patients</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2002</span>;<span class="volume">19</span>:393‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12027927" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Premixed+insulin+aspart+30+vs.+premixed+human+insulin+30/70+twice+daily:+a+randomized+trial+in+type+1+and+type+2+diabetic+patients+&author=BO+Boehm&author=PD+Home&author=C+Behrend&author=NM+Kamp&author=A+Lindholm&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">Bott 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0009"> <div class="citation-journal">Bott U, Ebrahim S, Hirschberger S, Skovlund SE. <span class="citation-title">Effect of the rapid‐acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2003</span>;<span class="volume">20</span>:626‐34. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12873289" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+the+rapid%E2%80%90acting+insulin+analogue+insulin+aspart+on+quality+of+life+and+treatment+satisfaction+in+patients+with+Type+1+diabetes+&author=U+Bott&author=S+Ebrahim&author=S+Hirschberger&author=SE+Skovlund&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">Bretzel 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0010"> <div class="citation-journal">Bretzel RG, Arnolds S, Medding J, Linn T. <span class="citation-title">A direct efficacy and safety of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>:1023‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15111514" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+direct+efficacy+and+safety+of+insulin+aspart,+human+soluble+insulin,+and+human+premix+insulin+(70/30)+in+patients+with+type+2+diabetes+&author=RG+Bretzel&author=S+Arnolds&author=J+Medding&author=T+Linn&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">Chan 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0011"> <div class="citation-journal">Chan WB, Chow DD, Yeung VTF, Chan JCN, So WY, Cochram CS. <span class="citation-title">Effect of insulin lispro on glycaemic control in chinese diabetic patients receiving twice‐daily regimens of insulin</span>. <span class="citation"> Chinese Medical Journal </span><span class="pubYear">2004</span>;<span class="volume">117</span>(9):1404‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15377436" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+insulin+lispro+on+glycaemic+control+in+chinese+diabetic+patients+receiving+twice%E2%80%90daily+regimens+of+insulin+&author=WB+Chan&author=DD+Chow&author=VTF+Yeung&author=JCN+Chan&author=WY+So&author=CS+Cochram&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">Ciofetta 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0012"> <div class="citation-journal">Ciofetta M, Lalli C, Sindaco P, Torlone E, Pampanelli S, Mauro L, et al. <span class="citation-title">Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(5):795‐800. [MEDLINE: 3] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10332684" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Contribution+of+postprandial+versus+interprandial+blood+glucose+to+HbA1c+in+type+1+diabetes+on+physiologic+intensive+therapy+with+lispro+insulin+at+mealtime+&author=M+Ciofetta&author=C+Lalli&author=P+Sindaco&author=E+Torlone&author=S+Pampanelli&author=L+Mauro&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">Deeb 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0013"> <div class="citation-journal">Deeb LC, Holcombe JH, Brunelle R, Zalani S, Brink S, Jenner M, et al. <span class="citation-title">Insulin lispro lowers postprandial glucose in prepubertal children with diabetes</span>. <span class="citation"> Pediatrics </span><span class="pubYear">2001</span>;<span class="volume">108</span>(5):1175‐9. [MEDLINE: 803] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11694699" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+lispro+lowers+postprandial+glucose+in+prepubertal+children+with+diabetes&author=LC+Deeb&author=JH+Holcombe&author=R+Brunelle&author=S+Zalani&author=S+Brink&author=M+Jenner&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">Del Sindaco 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0014"> <div class="citation-journal">Sindaco P, Ciofetta M, Lalli C, Perriello G, Pampanelli S, Torlone E, et al. <span class="citation-title">Use of the short‐acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: Importance of appropriate replacement of basal insulin and time‐interval injection‐meal</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1998</span>;<span class="volume">15</span>(7):592‐600. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9686700" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Use+of+the+short%E2%80%90acting+insulin+analogue+lispro+in+intensive+treatment+of+type+1+diabetes+mellitus:+Importance+of+appropriate+replacement+of+basal+insulin+and+time%E2%80%90interval+injection%E2%80%90meal+&author=P+Sindaco&author=M+Ciofetta&author=C+Lalli&author=G+Perriello&author=S+Pampanelli&author=E+Torlone&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">Ferguson 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0015"> <div class="citation-journal">Ferguson SC, Strachan MWJ, Janes JM, Frier BM. <span class="citation-title">Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin</span>. <span class="citation"> Diabetes/metabolism research and reviews </span><span class="pubYear">2001</span>;<span class="volume">17</span>(4):285‐91. [MEDLINE: 66] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Severe+hypoglycaemia+in+patients+with+type+1+diabetes+and+impaired+awareness+of+hypoglycaemia:+a+comparative+study+of+insulin+lispro+and+regular+human+insulin+&author=SC+Ferguson&author=MWJ+Strachan&author=JM+Janes&author=BM+Frier&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Ford‐Adams 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0016"> <div class="citation-journal">Ford‐Adams ME, Murphy NP, Moore EJ, Edge JA, Ong KL, Watts AP, et al. <span class="citation-title">Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2003</span>;<span class="volume">20</span>:656‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12873294" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+lispro:+a+potential+role+in+preventing+nocturnal+hypoglycaemia+in+young+children+with+diabetes+mellitus+&author=ME+Ford%E2%80%90Adams&author=NP+Murphy&author=EJ+Moore&author=JA+Edge&author=KL+Ong&author=AP+Watts&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">Gale 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0017"> <div class="citation-journal">Gale EAM. <span class="citation-title">A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2000</span>;<span class="volume">17</span>(3):209‐14. [MEDLINE: 439] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10784225" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized,+controlled+trial+comparing+insulin+lispro+with+human+soluble+insulin+in+patients+with+Type+1+diabetes+on+intensified+insulin+therapy+&author=EAM+Gale&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">Gallagher 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0018"> <div class="citation-journal">Gallagher A, Home PD. <span class="citation-title">The effect of improved post‐prandial blood glucose control on post‐prandial metabolism and markers of vascular risk in people with type 2 diabetes</span>. <span class="citation"> Diabetes research and clinical practice </span><span class="pubYear">2005</span>;<span class="volume">67</span>:196‐203. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15713351" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+improved+post%E2%80%90prandial+blood+glucose+control+on+post%E2%80%90prandial+metabolism+and+markers+of+vascular+risk+in+people+with+type+2+diabetes+&author=A+Gallagher&author=PD+Home&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">Garg 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0019"> <div class="citation-journal">Garg. <span class="citation-title">Optimal basal bolus insulin in type 1 diabetes: insulin glulisine insulin versus regular human insulin in combination with basal insulin glargine</span>. <span class="citation"> Endocrine Practice </span><span class="pubYear">2005</span>;<span class="volume">11</span>:11‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16033730" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Optimal+basal+bolus+insulin+in+type+1+diabetes:+insulin+glulisine+insulin+versus+regular+human+insulin+in+combination+with+basal+insulin+glargine+&author=+Garg&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">Hedman 2001 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0020"> <div class="citation-journal">Hedman CA, Orre‐Pettersson AC, Lindstrom T, Arnqvist HJ. <span class="citation-title">Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF‐I and IGFBP‐1 in type 1 diabetes</span>. <span class="citation"> Clinical Endocrinology </span><span class="pubYear">2001</span>;<span class="volume">55</span>(1):107‐12. [MEDLINE: 437] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11453959" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+with+insulin+lispro+changes+the+insulin+profile+but+does+not+affect+the+plasma+concentrations+of+IGF%E2%80%90I+and+IGFBP%E2%80%901+in+type+1+diabetes+&author=CA+Hedman&author=AC+Orre%E2%80%90Pettersson&author=T+Lindstrom&author=HJ+Arnqvist&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">Heller 1999 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0021"> <div class="citation-journal">Heller SR, Amiel SA, Mansell P. <span class="citation-title">Effect of the fast‐acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(10):1607‐11. [MEDLINE: 477] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10526722" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+the+fast%E2%80%90acting+insulin+analog+lispro+on+the+risk+of+nocturnal+hypoglycemia+during+intensified+insulin+therapy+&author=SR+Heller&author=SA+Amiel&author=P+Mansell&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">Heller 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0022"> <div class="citation-journal">Heller SR, Colagiuri S, Vaaler S, Wolffenbuttel BHR, Koelendorf K, et al. <span class="citation-title">Hypoglycaemia with insulin aspart: a double‐blind, randomised, cross over trial in subjects with tpye 1 diabetes</span>. <span class="citation"> Diabetic medicine : a journal of the British Diabetic Association </span><span class="pubYear">2004</span>;<span class="volume">21</span>:769‐75. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15209772" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Hypoglycaemia+with+insulin+aspart:+a+double%E2%80%90blind,+randomised,+cross+over+trial+in+subjects+with+tpye+1+diabetes+&author=SR+Heller&author=S+Colagiuri&author=S+Vaaler&author=BHR+Wolffenbuttel&author=K+Koelendorf&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">Herz 2002a {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0023"> <div class="citation-journal">Herz M, Profozic V, Arora V, Smircic‐Duvnjak L, Kovacevic I, Boras J, et al. <span class="citation-title">Effects of a fixed mixture of 25% insulin lispro and 75% NPL on plasma glucose during and after moderate physical exercise in patients with type 2 diabetes</span>. <span class="citation"> Current Medical Research and Opinion </span><span class="pubYear">2002</span>;<span class="volume">18</span>(4):188‐93. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12201618" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+a+fixed+mixture+of+25%+insulin+lispro+and+75%+NPL+on+plasma+glucose+during+and+after+moderate+physical+exercise+in+patients+with+type+2+diabetes+&author=M+Herz&author=V+Profozic&author=V+Arora&author=L+Smircic%E2%80%90Duvnjak&author=I+Kovacevic&author=J+Boras&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">Herz 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0024"> <div class="citation-journal">Herz M, Arora V, Campaigne BN, Scholtz HE, Potgieter MA, Mollentze W. <span class="citation-title">Humalog Mix25 improves 24‐hour profiles compared with the human insulin mixture 30/70 in patients wioth type 2 diabetes mellitus</span>. <span class="citation"> South African medical journal </span><span class="pubYear">2003</span>;<span class="volume">93</span>:219‐23. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12768948" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Humalog+Mix25+improves+24%E2%80%90hour+profiles+compared+with+the+human+insulin+mixture+30/70+in+patients+wioth+type+2+diabetes+mellitus+&author=M+Herz&author=V+Arora&author=BN+Campaigne&author=HE+Scholtz&author=MA+Potgieter&author=W+Mollentze&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">Holcombe 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0025"> <div class="citation-journal">Holcombe JH, Zalani S, Arora VK, Mast CJ. <span class="citation-title">Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2002</span>;<span class="volume">24</span>(4):626‐38. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+insulin+lispro+with+regular+human+insulin+for+the+treatment+of+type+1+diabetes+in+adolescents+&author=JH+Holcombe&author=S+Zalani&author=VK+Arora&author=CJ+Mast&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">Holleman 1997 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0026"> <div class="citation-other">Holleman F, Schmitt H, Rottiers R, Rees A, Symanowski S, Anderson JH. <span class="citation-title">Reduced frequency of severe hypoglycemia and coma in well‐controlled IDDM patients treated with insulin lispro</span>. Diabetes Care<span class="pubYear">1997</span>; Vol. 20, issue 12:1827‐32. [MEDLINE: 874] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Reduced+frequency+of+severe+hypoglycemia+and+coma+in+well%E2%80%90controlled+IDDM+patients+treated+with+insulin+lispro+&author=F+Holleman&author=H+Schmitt&author=R+Rottiers&author=A+Rees&author=S+Symanowski&author=JH+Anderson&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">Home 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0027"> <div class="citation-journal">Home PD, Lindholm A, Hylleberg B, Round P. <span class="citation-title">Improved glycemic control with insulin aspart: a multicenter randomized double‐blind crossover trial in type 1 diabetic patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(11):1904‐9. [MEDLINE: 878] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9802741" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+glycemic+control+with+insulin+aspart:+a+multicenter+randomized+double%E2%80%90blind+crossover+trial+in+type+1+diabetic+patients+&author=PD+Home&author=A+Lindholm&author=B+Hylleberg&author=P+Round&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">Home 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0028"> <div class="citation-journal">Home PD, Lindholm A, Riis A. <span class="citation-title">Insulin aspart vs. human insulin in the management of long‐term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2000</span>;<span class="volume">17</span>(11):762‐70. [MEDLINE: 112] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11131100" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+aspart+vs.+human+insulin+in+the+management+of+long%E2%80%90term+blood+glucose+control+in+Type+1+diabetes+mellitus:+a+randomized+controlled+trial+&author=PD+Home&author=A+Lindholm&author=A+Riis&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">Iwamoto 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0029"> <div class="citation-journal">Iwamoto Y, Akanuma Y, Niimi H, Sasaki N, Tajima N, Kawamori R, et al. <span class="citation-title">Comparison between insulin aspart and soluble human insulin in type 1 diabetes (IDDM) patients treated with basal‐bolus insulin therapy ‐ Phase III clinical trial in Japan</span>. <span class="citation"> Journal of the Japan Diabetes Society </span><span class="pubYear">2001</span>;<span class="volume">44</span>(10):799‐811. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+between+insulin+aspart+and+soluble+human+insulin+in+type+1+diabetes+(IDDM)+patients+treated+with+basal%E2%80%90bolus+insulin+therapy+%E2%80%90+Phase+III+clinical+trial+in+Japan+&author=Y+Iwamoto&author=Y+Akanuma&author=H+Niimi&author=N+Sasaki&author=N+Tajima&author=R+Kawamori&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">Jacobs 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0030"> <div class="citation-journal">Jacobs MAJM, Keulen ETP, Kanc K, Castelijn S, Scheffer P, Deville W, et al. <span class="citation-title">Metabolic efficacy of preprandial administration of Lys(B28),Pro(B29) human insulin analog in IDDM patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20</span>(8):1279‐86. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9250454" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+efficacy+of+preprandial+administration+of+Lys(B28),Pro(B29)+human+insulin+analog+in+IDDM+patients+&author=MAJM+Jacobs&author=ETP+Keulen&author=K+Kanc&author=S+Castelijn&author=P+Scheffer&author=W+Deville&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">Johansson 2000 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0031"> <div class="citation-journal">Johansson UB, Adamson UCK, Lins PES, Wredling RAM. <span class="citation-title">Improved blood glucose variability, HBA1C Insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish multicenter lispro insulin study</span>. <span class="citation"> Diabetes Metabolism </span><span class="pubYear">2000</span>;<span class="volume">26</span>(3):192‐6. [MEDLINE: 141] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10880892" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+blood+glucose+variability,+HBA1C+Insuman+Infusat+and+less+insulin+requirement+in+IDDM+patients+using+insulin+lispro+in+CSII.+The+Swedish+multicenter+lispro+insulin+study+&author=UB+Johansson&author=UCK+Adamson&author=PES+Lins&author=RAM+Wredling&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">Jovanovic 1999 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0032"> <div class="citation-journal">Jovanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, et al. <span class="citation-title">Metabolic and immunologic effects of insulin lispro in gestational diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(9):1422‐7. [MEDLINE: 494] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10480503" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+and+immunologic+effects+of+insulin+lispro+in+gestational+diabetes&author=L+Jovanovic&author=S+Ilic&author=DJ+Pettitt&author=K+Hugo&author=M+Gutierrez&author=RR+Bowsher&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Kotsanos 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0033"> <div class="citation-journal">Kotsanos JG, Vignati L, Huster L, Andrejasich C, Boggs MB, Jacobson AM, et al. <span class="citation-title">Health‐related quality‐of‐life results from multinational clinical trials of insulin lispro</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20</span>(6):948‐58. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9167105" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Health%E2%80%90related+quality%E2%80%90of%E2%80%90life+results+from+multinational+clinical+trials+of+insulin+lispro+&author=JG+Kotsanos&author=L+Vignati&author=L+Huster&author=C+Andrejasich&author=MB+Boggs&author=AM+Jacobson&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">Mecacci 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0034"> <div class="citation-journal">Mecacci F, Carignani L, Cioni R, Bartoli E, Parretti E, Torre P, et al. <span class="citation-title">Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non‐diabetic pregnant women</span>. <span class="citation"> European journal of obstetrics, gynecology, and reproductive biology </span><span class="pubYear">2003</span>;<span class="volume">111</span>:19‐24. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14557006" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Maternal+metabolic+control+and+perinatal+outcome+in+women+with+gestational+diabetes+treated+with+regular+or+lispro+insulin:+comparison+with+non%E2%80%90diabetic+pregnant+women+&author=F+Mecacci&author=L+Carignani&author=R+Cioni&author=E+Bartoli&author=E+Parretti&author=P+Torre&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Persson 2002 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0035"> <div class="citation-journal">Persson B, Swahn ML, Hjertberg R, Hanson U, Nord E, Nordlander E, et al. <span class="citation-title">Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2002</span>;<span class="volume">58</span>:115‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12213353" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+lispro+therapy+in+pregnancies+complicated+by+type+1+diabetes+mellitus&author=B+Persson&author=ML+Swahn&author=R+Hjertberg&author=U+Hanson&author=E+Nord&author=E+Nordlander&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">Provenzano 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0036"> <div class="citation-journal">Provenzano C, Vero R, Oliva A, Leto G, Puccio L, Vecci E, et al. <span class="citation-title">Lispro insulin in Type 1 diabetic patients on a mediterranean or normal diet: A randomized, cross‐over comparative study with regular insulin</span>. <span class="citation"> Diabetes, nutrition &amp; metabolism </span><span class="pubYear">2001</span>;<span class="volume">14</span>(3):133‐9. [MEDLINE: 82] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11476360" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lispro+insulin+in+Type+1+diabetic+patients+on+a+mediterranean+or+normal+diet:+A+randomized,+cross%E2%80%90over+comparative+study+with+regular+insulin+&author=C+Provenzano&author=R+Vero&author=A+Oliva&author=G+Leto&author=L+Puccio&author=E+Vecci&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">Raskin 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0037"> <div class="citation-journal">Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L. <span class="citation-title">Use of insulin aspart, a fast‐acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(5):583‐8. [MEDLINE: 149] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10834413" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Use+of+insulin+aspart,+a+fast%E2%80%90acting+insulin+analog,+as+the+mealtime+insulin+in+the+management+of+patients+with+type+1+diabetes+&author=P+Raskin&author=RA+Guthrie&author=L+Leiter&author=A+Riis&author=L+Jovanovic&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Raskin 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0038"> <div class="citation-journal">Raskin P, Holcombe JH, Tamborlane WV, Malone JI, Strowig S, Ahern JA, et al. <span class="citation-title">A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump</span>. <span class="citation"> The Journal of diabetic complications </span><span class="pubYear">2001</span>;<span class="volume">15</span>(6):295‐300. [MEDLINE: 46] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+insulin+lispro+and+buffered+regular+human+insulin+administered+via+continuous+subcutaneous+insulin+infusion+pump+&author=P+Raskin&author=JH+Holcombe&author=WV+Tamborlane&author=JI+Malone&author=S+Strowig&author=JA+Ahern&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Recasens 2003 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0039"> <div class="citation-journal">Recasens M, Aguilera E, Morinigo R, Casamitjana R, Nicoletti F, Gomis R, et al. <span class="citation-title">Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving ß‐cell function at onset of type 1 diabetes mellitus</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2003</span>;<span class="volume">60</span>:153‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12757987" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+lispro+is+as+effective+as+regular+insulin+in+optimising+metabolic+control+and+preserving+%C3%9F%E2%80%90cell+function+at+onset+of+type+1+diabetes+mellitus+&author=M+Recasens&author=E+Aguilera&author=R+Morinigo&author=R+Casamitjana&author=F+Nicoletti&author=R+Gomis&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">Renner 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0040"> <div class="citation-journal">Renner R, Pfuetzner A, Trautmann ME, Harzer O, Sauter K, Landgraf R. <span class="citation-title">Use of insulin lispro in continuous subcutaneous insulin infusion treatment</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(5):784‐8. [MEDLINE: 1035] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10332682" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Use+of+insulin+lispro+in+continuous+subcutaneous+insulin+infusion+treatment&author=R+Renner&author=A+Pfuetzner&author=ME+Trautmann&author=O+Harzer&author=K+Sauter&author=R+Landgraf&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">Roach 1999a {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0041"> <div class="citation-journal">Roach P, Trautmann ME, Arora V, Sun B, Anderson JH. <span class="citation-title">Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro‐protamine formulations, insulin lispro Mix25 and insulin lispro Mix50</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">1999</span>;<span class="volume">21</span>(3):523‐34. [MEDLINE: 175] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10321421" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+postprandial+blood+glucose+control+and+reduced+nocturnal+hypoglycemia+during+treatment+with+two+novel+insulin+lispro%E2%80%90protamine+formulations,+insulin+lispro+Mix25+and+insulin+lispro+Mix50+&author=P+Roach&author=ME+Trautmann&author=V+Arora&author=B+Sun&author=JH+Anderson&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">Roach 1999b {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0042"> <div class="citation-journal">Roach P, Yue L, Arora V. <span class="citation-title">Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine‐based insulin lispro formulation</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(8):1258‐61. [MEDLINE: 1041] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10480767" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+postprandial+glycemic+control+during+treatment+with+Humalog+Mix25,+a+novel+protamine%E2%80%90based+insulin+lispro+formulation+&author=P+Roach&author=L+Yue&author=V+Arora&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0043"> <div class="reference-title-banner"> <h4 class="title">Ross 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0043"> <div class="citation-journal">Ross SA, Zinman B, Campos RV, Strack T. <span class="citation-title">A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents</span>. <span class="citation"> Clinical and investigative medicine </span><span class="pubYear">2001</span>;<span class="volume">24</span>(6):292‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11767232" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparative+study+of+insulin+lispro+and+human+regular+insulin+in+patients+with+type+2+diabetes+mellitus+and+secondary+failure+of+oral+hypoglycemic+agents+&author=SA+Ross&author=B+Zinman&author=RV+Campos&author=T+Strack&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0044"> <div class="reference-title-banner"> <h4 class="title">Schmauss 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0044"> <div class="citation-journal">Schmauss S, Koenig A, Landgraf R. <span class="citation-title">Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1998</span>;<span class="volume">15</span>(3):247‐9. [MEDLINE: 512] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9545126" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Human+insulin+analogue+[LYS(B28),+PRO(B29)]:+the+ideal+pump+insulin?&author=S+Schmauss&author=A+Koenig&author=R+Landgraf&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0045"> <div class="reference-title-banner"> <h4 class="title">Skrha 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0045"> <div class="citation-journal">Skrha J, Smahelova A, Andel M, Vrtovec M, Subic J, Kreze A, et al. <span class="citation-title">Insulin lispro improves postprandial glucose control in patients with diabetes mellitus</span> [Inzulin lispro zlepsuje postprandialni glykemii u pacientu s diabetes mellitus]. <span class="citation"> Sbornik lekarsky </span><span class="pubYear">2002</span>;<span class="volume">103</span>(1):15‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12448933" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+lispro+improves+postprandial+glucose+control+in+patients+with+diabetes+mellitus&author=J+Skrha&author=A+Smahelova&author=M+Andel&author=M+Vrtovec&author=J+Subic&author=A+Kreze&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0046"> <div class="reference-title-banner"> <h4 class="title">Tubiana‐Rufi 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0046"> <div class="citation-journal">Tubiana‐Rufi N, Coutant R, Bloch J, Munz‐Licha G, Delcroix C, Montaud‐Ragideau N, et al. <span class="citation-title">Special management of insulin lispro in continuous subcutaneous insulininfusion in young diabetic children: a randomized cross‐over study</span>. <span class="citation"> Hormone research </span><span class="pubYear">2004</span>;<span class="volume">62</span>:265‐71. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15523183" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Special+management+of+insulin+lispro+in+continuous+subcutaneous+insulininfusion+in+young+diabetic+children:+a+randomized+cross%E2%80%90over+study+&author=N+Tubiana%E2%80%90Rufi&author=R+Coutant&author=J+Bloch&author=G+Munz%E2%80%90Licha&author=C+Delcroix&author=N+Montaud%E2%80%90Ragideau&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0047"> <div class="reference-title-banner"> <h4 class="title">Tupola 2001 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0047"> <div class="citation-journal">Tupola S, Komulainen J, Jääskeläinen J, Sipilä I. <span class="citation-title">Post‐prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2001</span>;<span class="volume">18</span>:654‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11553203" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Post%E2%80%90prandial+insulin+lispro+vs.+human+regular+insulin+in+prepubertal+children+with+Type+1+diabetes+mellitus+&author=S+Tupola&author=J+Komulainen&author=J+J%C3%A4%C3%A4skel%C3%A4inen&author=I+Sipil%C3%A4&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0048"> <div class="reference-title-banner"> <h4 class="title">Vignati 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0048"> <div class="citation-journal">Vignati L, Anderson JH, Iversen PW. <span class="citation-title">Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin‐dependent or non‐insulin‐dependent diabetes</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">1997</span>;<span class="volume">19</span>(6):1408‐21. [MEDLINE: 533] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9444449" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+insulin+lispro+in+combination+with+NPH+human+insulin+twice+per+day+in+patients+with+insulin%E2%80%90dependent+or+non%E2%80%90insulin%E2%80%90dependent+diabetes+&author=L+Vignati&author=JH+Anderson&author=PW+Iversen&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD003287-bbs2-0049"> <div class="reference-title-banner"> <h4 class="title">Zinman 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0049"> <div class="citation-journal">Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T. <span class="citation-title">Insulin lispro in CSII: Results of a double‐blind crossover study</span>. <span class="citation"> Diabetes </span><span class="pubYear">1997</span>;<span class="volume">46</span>(3):440‐3. [MEDLINE: 287] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9032100" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+lispro+in+CSII:+Results+of+a+double%E2%80%90blind+crossover+study&author=B+Zinman&author=H+Tildesley&author=JL+Chiasson&author=E+Tsui&author=T+Strack&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD003287-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD003287-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD003287-bbs1-0003">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0050"> <div class="reference-title-banner"> <h4 class="title">Bastyr 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0050"> <div class="citation-journal">Bastyr III EJ, Huang Y, Brunelle RL, Vignati L, Cox DJ, Kotsanos JG. <span class="citation-title">Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: Experience with insulin lispro</span>. <span class="citation"> Diabetes Obesity and Metabolism </span><span class="pubYear">2000</span>;<span class="volume">2</span>(1):39‐46. [MEDLINE: 44] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Factors+associated+with+nocturnal+hypoglycaemia+among+patients+with+type+2+diabetes+new+to+insulin+therapy:+Experience+with+insulin+lispro+&author=EJ+BastyrIII&author=Y+Huang&author=RL+Brunelle&author=L+Vignati&author=DJ+Cox&author=JG+Kotsanos&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0051"> <div class="reference-title-banner"> <h4 class="title">Boehm 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0051"> <div class="citation-journal">Boehm BO, Vaz JA, Bronsted L, Home PD. <span class="citation-title">Long‐term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes</span>. <span class="citation"> European journal of internal medicine </span><span class="pubYear">2004</span>;<span class="volume">15</span>(8):496‐502. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15668084" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+efficacy+and+safety+of+biphasic+insulin+aspart+in+patients+with+type+2+diabetes&author=BO+Boehm&author=JA+Vaz&author=L+Bronsted&author=PD+Home&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0052"> <div class="reference-title-banner"> <h4 class="title">Colombel 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0052"> <div class="citation-journal">Colombel A, Murat A, Krempf M, Kuchly‐Anton B, Charbonnel B. <span class="citation-title">Improvement of blood glucose control in type 1 diabetic patients treated with lispro and multiple NPH injections</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1999</span>;<span class="volume">16</span>(4):319‐24. [MEDLINE: 169] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10220206" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improvement+of+blood+glucose+control+in+type+1+diabetic+patients+treated+with+lispro+and+multiple+NPH+injections+&author=A+Colombel&author=A+Murat&author=M+Krempf&author=B+Kuchly%E2%80%90Anton&author=B+Charbonnel&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0053"> <div class="reference-title-banner"> <h4 class="title">Cypryk 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0053"> <div class="citation-journal">Cypryk K, Sobczak M, Petynska‐Marczewska M, Zawodniak‐Szalapska M, Szymczak W, Wilczynski J, et al. <span class="citation-title">Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy</span>. <span class="citation"> Medical science monitor : international medical journal of experimental and clinical research </span><span class="pubYear">2004</span>;<span class="volume">10</span>(2):29‐32. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pregnancy+complications+and+perinatal+outcome+in+diabetic+women+treated+with+Humalog+(insulin+lispro)+or+regular+human+insulin+during+pregnancy+&author=K+Cypryk&author=M+Sobczak&author=M+Petynska%E2%80%90Marczewska&author=M+Zawodniak%E2%80%90Szalapska&author=W+Szymczak&author=J+Wilczynski&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0054"> <div class="reference-title-banner"> <h4 class="title">DeVries 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0054"> <div class="citation-journal">DeVries JH, Lindholm A, Jacobsen JL, Heine RJ, Home PD. <span class="citation-title">A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in people with Type 1 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2003</span>;<span class="volume">20</span>:312‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12675646" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+trial+of+insulin+aspart+with+intensified+basal+NPH+insulin+supplementation+in+people+with+Type+1+diabetes+&author=JH+DeVries&author=A+Lindholm&author=JL+Jacobsen&author=RJ+Heine&author=PD+Home&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0055"> <div class="reference-title-banner"> <h4 class="title">Fineberg 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0055"> <div class="citation-journal">Fineberg NS, Fineberg SE, Anderson JH, Birkett MA, Gibson RG, Hufferd S. <span class="citation-title">Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin</span>. <span class="citation"> Diabetes </span><span class="pubYear">1996</span>;<span class="volume">45</span>(12):1750‐4. [MEDLINE: 2] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8922361" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Immunologic+effects+of+insulin+lispro+[Lys+(B28),+Pro+(B29)+human+insulin]+in+IDDM+and+NIDDM+patients+previously+treated+with+insulin+&author=NS+Fineberg&author=SE+Fineberg&author=JH+Anderson&author=MA+Birkett&author=RG+Gibson&author=S+Hufferd&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0056"> <div class="reference-title-banner"> <h4 class="title">Garg 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0056"> <div class="citation-journal">Garg SK, Carmain JA, Braddy KC, Anderson JH, Vignati L, Jennings MK, et al. <span class="citation-title">Pre‐meal insulin analogue insulin lispro vs humulin insulin treatment in young subjects with type 1 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1996</span>;<span class="volume">13</span>(1):47‐52. [MEDLINE: 579] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8741812" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pre%E2%80%90meal+insulin+analogue+insulin+lispro+vs+humulin+insulin+treatment+in+young+subjects+with+type+1+diabetes+&author=SK+Garg&author=JA+Carmain&author=KC+Braddy&author=JH+Anderson&author=L+Vignati&author=MK+Jennings&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0057"> <div class="reference-title-banner"> <h4 class="title">Garg 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0057"> <div class="citation-journal">Garg SK, Anderson JH, Gerard LA, Mackenzie TA, Gottlieb PA, Jennings MK, et al. <span class="citation-title">Impact of insulin lispro on HbA1c values in insulin pump users</span>. <span class="citation"> Diabetes Obesity and Metabolism </span><span class="pubYear">2000</span>;<span class="volume">2</span>(5):307‐11. [MEDLINE: 842] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Impact+of+insulin+lispro+on+HbA1c+values+in+insulin+pump+users&author=SK+Garg&author=JH+Anderson&author=LA+Gerard&author=TA+Mackenzie&author=PA+Gottlieb&author=MK+Jennings&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0058"> <div class="reference-title-banner"> <h4 class="title">Heller 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0058"> <div class="citation-journal">Heller SR, Amiel SA, Evans ML, Kong MF, Macdonald IA, Peacey SR. <span class="citation-title">Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2002</span>;<span class="volume">4</span>:106‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Does+insulin+lispro+preserve+the+physiological+defences+to+hypoglycaemia+during+intensive+insulin+therapy+with+a+conventional+basal+bolus+regimen?+&author=SR+Heller&author=SA+Amiel&author=ML+Evans&author=MF+Kong&author=IA+Macdonald&author=SR+Peacey&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0059"> <div class="reference-title-banner"> <h4 class="title">Herz 2002b {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0059"> <div class="citation-journal">Herz M, Arora V, Sun B, Ferguson SC, Bolli GB, Frier BM. <span class="citation-title">Basal‐bolus insulin therapy in type 1 diabetes: comparative study of pre‐meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2002</span>;<span class="volume">19</span>:917‐23. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12421428" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Basal%E2%80%90bolus+insulin+therapy+in+type+1+diabetes:+comparative+study+of+pre%E2%80%90meal+administration+of+a+fixed+mixture+of+insulin+lispro+(50%)+and+neutral+protamine+lispro+(50%)+with+human+soluble+insulin+&author=M+Herz&author=V+Arora&author=B+Sun&author=SC+Ferguson&author=GB+Bolli&author=BM+Frier&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0060"> <div class="reference-title-banner"> <h4 class="title">Janssen 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0060"> <div class="citation-journal">Janssen MMJ, Snoek FJ, Masurel N, Hoogma RPLM, Deville WL, Popp‐Snijders C, et al. <span class="citation-title">Optimized basal‐bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: No favorable effects on glycemic control, physiological responses to hypoglycemia, well‐being, or treatment satisfaction</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(5):629‐33. [MEDLINE: 148] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10834421" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Optimized+basal%E2%80%90bolus+therapy+using+a+fixed+mixture+of+75%+lispro+and+25%+NPL+insulin+in+type+1+diabetes+patients:+No+favorable+effects+on+glycemic+control,+physiological+responses+to+hypoglycemia,+well%E2%80%90being,+or+treatment+satisfaction+&author=MMJ+Janssen&author=FJ+Snoek&author=N+Masurel&author=RPLM+Hoogma&author=WL+Deville&author=C+Popp%E2%80%90Snijders&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0061"> <div class="reference-title-banner"> <h4 class="title">Jansson 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0061"> <div class="citation-journal">Jansson PA, Ebeling P, Smith U, Conget I, Coves MJ, Gomis R, et al. <span class="citation-title">Improved glycemic control can be better maintained with insulin lispro than with human regular insulin</span>. <span class="citation"> Diabetes, Nutrition and Metabolism Clinical and Experimental </span><span class="pubYear">1998</span>;<span class="volume">11</span>(3):194‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+glycemic+control+can+be+better+maintained+with+insulin+lispro+than+with+human+regular+insulin+&author=PA+Jansson&author=P+Ebeling&author=U+Smith&author=I+Conget&author=MJ+Coves&author=R+Gomis&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0062"> <div class="reference-title-banner"> <h4 class="title">Kaplan 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0062"> <div class="citation-journal">Kaplan W, Rodriguez LM, Smith OE, Haymond MW, Heptulla RA. <span class="citation-title">Effects of mixing glargine and short‐acting insulin analogs on glucose control</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>(11):2739‐40. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15505016" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+mixing+glargine+and+short%E2%80%90acting+insulin+analogs+on+glucose+control&author=W+Kaplan&author=LM+Rodriguez&author=OE+Smith&author=MW+Haymond&author=RA+Heptulla&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0063"> <div class="reference-title-banner"> <h4 class="title">Kaufman 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0063"> <div class="citation-journal">Kaufman FR. <span class="citation-title">Use of insulin pump therapy at nighttime only for children 7‐10 years of age with type 1 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(5):579‐82. [MEDLINE: 472] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10834412" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Use+of+insulin+pump+therapy+at+nighttime+only+for+children+7%E2%80%9010+years+of+age+with+type+1+diabetes+&author=FR+Kaufman&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0064"> <div class="reference-title-banner"> <h4 class="title">Kilo 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0064"> <div class="citation-journal">Kilo C, Mezitis N, Jain R, Mersey J, McGill J, Raskin P. <span class="citation-title">Starting patients with type 2 diabetes on insulin therapy using once‐daily injections of biphasic insulin aspart 70/30, biphasic insulin 70/30, or NPH insulin combination with metformin</span>. <span class="citation"> Journal of diabetes and its complications </span><span class="pubYear">2003</span>;<span class="volume">17</span>:307‐13. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14583174" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Starting+patients+with+type+2+diabetes+on+insulin+therapy+using+once%E2%80%90daily+injections+of+biphasic+insulin+aspart+70/30,+biphasic+insulin+70/30,+or+NPH+insulin+combination+with+metformin+&author=C+Kilo&author=N+Mezitis&author=R+Jain&author=J+Mersey&author=J+McGill&author=P+Raskin&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0065"> <div class="reference-title-banner"> <h4 class="title">Krzymien 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0065"> <div class="citation-journal">Krzymien J, Rosinski G, Erhmann A, Karnafel W. <span class="citation-title">Efficacy and safety of continuous subcutaneous insulin infusion using Lispro analog in treatment of patients with new diagnosed type 1 diabetes</span>. <span class="citation"> Diabetologia Polska </span><span class="pubYear">2001</span>;<span class="volume">7 Suppl 1</span>:16‐22. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+continuous+subcutaneous+insulin+infusion+using+Lispro+analog+in+treatment+of+patients+with+new+diagnosed+type+1+diabetes+&author=J+Krzymien&author=G+Rosinski&author=A+Erhmann&author=W+Karnafel&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0066"> <div class="reference-title-banner"> <h4 class="title">Lalli 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0066"> <div class="citation-journal">Lalli C, Ciofetta M, Sindaco P, Torlone E, Pampanelli S, Compagnucci P, et al. <span class="citation-title">Long‐term intensive treatment of type 1 diabetes with the short‐acting insulin analog lispro in variable combination with NPH insulin at mealtime</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(3):468‐77. [MEDLINE: 178] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10097931" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+intensive+treatment+of+type+1+diabetes+with+the+short%E2%80%90acting+insulin+analog+lispro+in+variable+combination+with+NPH+insulin+at+mealtime+&author=C+Lalli&author=M+Ciofetta&author=P+Sindaco&author=E+Torlone&author=S+Pampanelli&author=P+Compagnucci&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0067"> <div class="reference-title-banner"> <h4 class="title">Laube 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0067"> <div class="citation-journal">Laube H, Heller M, Liersch J, Mäser E, Linn Th. <span class="citation-title">Experience with Lispro‐insulin in the intensified therapy of IDDM and NIDDM patients</span>. <span class="citation"> Diabetes und Stoffwechsel </span><span class="pubYear">1996</span>;<span class="volume">5</span>(6):273‐6. [MEDLINE: 569] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Experience+with+Lispro%E2%80%90insulin+in+the+intensified+therapy+of+IDDM+and+NIDDM+patients&author=H+Laube&author=M+Heller&author=J+Liersch&author=E+M%C3%A4ser&author=Th+Linn&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0068"> <div class="reference-title-banner"> <h4 class="title">Loba 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0068"> <div class="citation-journal">Loba J. <span class="citation-title">Glycemic control in obese insulin‐resistant type 2 diabetic patients treated with insulin lispro</span>. <span class="citation"> Diabetologia Polska </span><span class="pubYear">2001</span>;<span class="volume">7 Suppl 1</span>:29‐34. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycemic+control+in+obese+insulin%E2%80%90resistant+type+2+diabetic+patients+treated+with+insulin+lispro+&author=J+Loba&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0069"> <div class="reference-title-banner"> <h4 class="title">Martin 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0069"> <div class="citation-journal">Martin D, Licha‐Müntz G, Grasset E, Greneche MO, Nouet D, Francois L, et al. <span class="citation-title">Efficacy of humalog injections before an afternoon meal and their acceptance by children and adolescents with type 1 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2002</span>;<span class="volume">19</span>:1026‐31. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12647845" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+humalog+injections+before+an+afternoon+meal+and+their+acceptance+by+children+and+adolescents+with+type+1+diabetes+&author=D+Martin&author=G+Licha%E2%80%90M%C3%BCntz&author=E+Grasset&author=MO+Greneche&author=D+Nouet&author=L+Francois&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0070"> <div class="reference-title-banner"> <h4 class="title">McSorley 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0070"> <div class="citation-journal">Sorley PT, Bell PM, Vestergard Jacobsen L, Kristensen A, Lindholm A. <span class="citation-title">Twice‐daily biphasic insulin aspart 30 versus biphasic hunam insulin 30: a double‐blind crossover study in adults with type 2 diabetes mellitus</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2002</span>;<span class="volume">24</span>(4):530‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12017398" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Twice%E2%80%90daily+biphasic+insulin+aspart+30+versus+biphasic+hunam+insulin+30:+a+double%E2%80%90blind+crossover+study+in+adults+with+type+2+diabetes+mellitus+&author=PT+Sorley&author=PM+Bell&author=L+VestergardJacobsen&author=A+Kristensen&author=A+Lindholm&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0071"> <div class="reference-title-banner"> <h4 class="title">Melki 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0071"> <div class="citation-journal">Melki V, Renard E, Lassmann‐Vague V, Boivin S, Guerci B, Hanaire‐Broutin H, et al. <span class="citation-title">Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(6):977‐82. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9614617" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improvement+of+HbA1c+and+blood+glucose+stability+in+IDDM+patients+treated+with+lispro+insulin+analog+in+external+pumps+&author=V+Melki&author=E+Renard&author=V+Lassmann%E2%80%90Vague&author=S+Boivin&author=B+Guerci&author=H+Hanaire%E2%80%90Broutin&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0072"> <div class="reference-title-banner"> <h4 class="title">Nielsen 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0072"> <div class="citation-journal">Nielsen FS, Jorgensen LN, Ipsen M, Voldsgaard AI, Parving HH. <span class="citation-title">Long‐term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1995</span>;<span class="volume">38</span>(5):592‐8. [MEDLINE: 322] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7489843" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+comparison+of+human+insulin+analogue+B10Asp+and+soluble+human+insulin+in+IDDM+patients+on+a+basal/bolus+insulin+regimen+&author=FS+Nielsen&author=LN+Jorgensen&author=M+Ipsen&author=AI+Voldsgaard&author=HH+Parving&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0073"> <div class="reference-title-banner"> <h4 class="title">Petersen 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0073"> <div class="citation-journal">Petersen KG, Schiwitz B, Khalaf AN. <span class="citation-title">Intensive insulin therapy in type II diabetic patients. Comparison of regular insulin and a rapidly acting insulin analogue</span>. <span class="citation"> Münchener Medizinische Wochenschrift </span><span class="pubYear">1995</span>;<span class="volume">137</span>(27):467‐70. [MEDLINE: 591] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensive+insulin+therapy+in+type+II+diabetic+patients.+Comparison+of+regular+insulin+and+a+rapidly+acting+insulin+analogue+&author=KG+Petersen&author=B+Schiwitz&author=AN+Khalaf&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0074"> <div class="reference-title-banner"> <h4 class="title">Pfuetzner 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0074"> <div class="citation-journal">Pfuetzner A, Kuestner E, Forst T, Schulze‐Schleppinghoff B, Trautmann ME, Haslbeck M, et al. <span class="citation-title">Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes</span>. <span class="citation"> Experimental and clinical endocrinology &amp; diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association </span><span class="pubYear">1996</span>;<span class="volume">104</span>(1):25‐30. [MEDLINE: 313] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensive+insulin+therapy+with+insulin+lispro+in+patients+with+type+1+diabetes+reduces+the+frequency+of+hypoglycemic+episodes+&author=A+Pfuetzner&author=E+Kuestner&author=T+Forst&author=B+Schulze%E2%80%90Schleppinghoff&author=ME+Trautmann&author=M+Haslbeck&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0075"> <div class="reference-title-banner"> <h4 class="title">Roach 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0075"> <div class="citation-journal">Roach P, Strack T, Arora V, Zhao Z. <span class="citation-title">Improved glycemic control with the use of self‐prepared mixtures of insulin lispro and insulin lispro protamine suspension in patioents with types 1 and 2 diabetes</span>. <span class="citation"> International journal of clinical practice </span><span class="pubYear">2001</span>;<span class="volume">55</span>(3):177‐82. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11351771" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+glycemic+control+with+the+use+of+self%E2%80%90prepared+mixtures+of+insulin+lispro+and+insulin+lispro+protamine+suspension+in+patioents+with+types+1+and+2+diabetes+&author=P+Roach&author=T+Strack&author=V+Arora&author=Z+Zhao&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0076"> <div class="reference-title-banner"> <h4 class="title">Sargin 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0076"> <div class="citation-journal">Sargin H, Sargin M, Altuntas Y, Sengül AM, Orbay E, Seber S, et al. <span class="citation-title">Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes</span>. <span class="citation"> Diabetes research and clinical practice </span><span class="pubYear">2003</span>;<span class="volume">62</span>:79‐86. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14581144" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+lunch+and+bedtime+NPH+insulin+plus+mealtime+insulin+Lispro+therapy+with+premeal+regular+insulin+plus+bedtime+NPH+insulin+therapy+in+type+2+diabetes+&author=H+Sargin&author=M+Sargin&author=Y+Altuntas&author=AM+Seng%C3%BCl&author=E+Orbay&author=S+Seber&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0077"> <div class="reference-title-banner"> <h4 class="title">Schernthaner 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0077"> <div class="citation-journal">Schernthaner G, Kopp HP, Ristic S, Muzyka B, Peter L, Mitteregger G. <span class="citation-title">Metabolic control in patients with type 2 diabetes using humalog mix 50 injected three times daily: crossover comparison with human insulin 30/70</span>. <span class="citation"> Hormone and metabolic research </span><span class="pubYear">2004</span>;<span class="volume">36</span>(3):188‐93. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15057674" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+control+in+patients+with+type+2+diabetes+using+humalog+mix+50+injected+three+times+daily:+crossover+comparison+with+human+insulin+30/70+&author=G+Schernthaner&author=HP+Kopp&author=S+Ristic&author=B+Muzyka&author=L+Peter&author=G+Mitteregger&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0078"> <div class="reference-title-banner"> <h4 class="title">Tamas 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0078"> <div class="citation-journal">Tamas G, Marre M, Astorga R, Dedov I, Jacobsen J, Lindholm A. <span class="citation-title">Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study</span>. <span class="citation"> Diabetes research and clinical practice </span><span class="pubYear">2001</span>;<span class="volume">54</span>(2):105‐14. [MEDLINE: 50] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11640994" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycaemic+control+in+type+1+diabetic+patients+using+optimised+insulin+aspart+or+human+insulin+in+a+randomised+multinational+study+&author=G+Tamas&author=M+Marre&author=R+Astorga&author=I+Dedov&author=J+Jacobsen&author=A+Lindholm&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0079"> <div class="reference-title-banner"> <h4 class="title">Tsui 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0079"> <div class="citation-journal">Tsui EYL, Chiasson JL, Tildesley H, Barnie A, Simkins S, Strack T, et al. <span class="citation-title">Counterregulatory hormone responses after long‐term continuous subcutaneous insulin infusion with lispro insulin</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>:93‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9538976" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Counterregulatory+hormone+responses+after+long%E2%80%90term+continuous+subcutaneous+insulin+infusion+with+lispro+insulin+&author=EYL+Tsui&author=JL+Chiasson&author=H+Tildesley&author=A+Barnie&author=S+Simkins&author=T+Strack&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD003287-bbs2-0080"> <div class="reference-title-banner"> <h4 class="title">Velussi 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD003287-bib-0080"> <div class="citation-journal">Velussi M. <span class="citation-title">Lispro insulin treatment in comparison with regular human insulin in Type 2 diabetic patients living in nursing homes</span>. <span class="citation"> Diabetes, nutrition &amp; metabolism </span><span class="pubYear">2002</span>;<span class="volume">15</span>(2):96‐100. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12059098" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lispro+insulin+treatment+in+comparison+with+regular+human+insulin+in+Type+2+diabetic+patients+living+in+nursing+homes+&author=M+Velussi&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD003287-bbs1-0003"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD003287-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD003287-bbs1-0002">excluded studies</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0081"> <div class="reference-title-banner"> <h4 class="title">ADA 1997</h4> </div> <div class="bibliography-section" id="CD003287-bib-0081"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">Report of the Expert Committee on the Diagnosis and Classification of diabetes mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20</span>:1183‐97. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9203460" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0082"> <div class="reference-title-banner"> <h4 class="title">Ahmed 1998</h4> </div> <div class="bibliography-section" id="CD003287-bib-0082"> <div class="citation-journal">Ahmed ABE, Home PD. <span class="citation-title">The effect of the insulin analog lispro on night time blood glucose control in type 1 diabetic patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>:32‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9538967" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+the+insulin+analog+lispro+on+night+time+blood+glucose+control+in+type+1+diabetic+patients+&author=ABE+Ahmed&author=PD+Home&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0083"> <div class="reference-title-banner"> <h4 class="title">Akalin 1997</h4> </div> <div class="bibliography-section" id="CD003287-bib-0083"> <div class="citation-journal">Akalin S, Erbas T, Yilmaz MT, Ilkova H, Satman I, Ersanli Z, et al. <span class="citation-title">Safety and efficacy of [Lys(B28), Pro(29)]‐human insulin in patients with diabetes mellitus</span>. <span class="citation"> Israel Journal of Medical Sciences </span><span class="pubYear">1997</span>;<span class="volume">33</span>:716‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9434806" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Safety+and+efficacy+of+[Lys(B28),+Pro(29)]%E2%80%90human+insulin+in+patients+with+diabetes+mellitus+&author=S+Akalin&author=T+Erbas&author=MT+Yilmaz&author=H+Ilkova&author=I+Satman&author=Z+Ersanli&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0084"> <div class="reference-title-banner"> <h4 class="title">Berger 2001</h4> </div> <div class="bibliography-section" id="CD003287-bib-0084"> <div class="citation-book">Berger M, Jörgens V. <span class="citation">Insulintherapie in der Praxis</span>. Berlin, Heidelberg: Springer Verlag, <span class="pubYear">2001</span>:1‐327. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0085"> <div class="reference-title-banner"> <h4 class="title">Bolli 1999</h4> </div> <div class="bibliography-section" id="CD003287-bib-0085"> <div class="citation-journal">Bolli GB, Marchi RD, Park GD, Pramming S, Koivisto VA. <span class="citation-title">Insulin analogues and their potential in the management of diabetes mellitus</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1999</span>;<span class="volume">42</span>:1151‐67. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10525654" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+analogues+and+their+potential+in+the+management+of+diabetes+mellitus&author=GB+Bolli&author=RD+Marchi&author=GD+Park&author=S+Pramming&author=VA+Koivisto&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0086"> <div class="reference-title-banner"> <h4 class="title">Bott 1994</h4> </div> <div class="bibliography-section" id="CD003287-bib-0086"> <div class="citation-journal">Bott U, Mühlhauser I, Overmann H, Berger M. <span class="citation-title">Validation of a diabetes‐specific quality of life scale for patients with type 1 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>:757‐69. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9589237" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Validation+of+a+diabetes%E2%80%90specific+quality+of+life+scale+for+patients+with+type+1+diabetes&author=U+Bott&author=I+M%C3%BChlhauser&author=H+Overmann&author=M+Berger&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0087"> <div class="reference-title-banner"> <h4 class="title">Bradley 1990</h4> </div> <div class="bibliography-section" id="CD003287-bib-0087"> <div class="citation-journal">Bradley C, Lewis KS. <span class="citation-title">Measures of psychological well‐being and treatment satisfaction developed from the responses of people with tablet‐treated diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1990</span>;<span class="volume">7</span>(5):445‐51. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2142043" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Measures+of+psychological+well%E2%80%90being+and+treatment+satisfaction+developed+from+the+responses+of+people+with+tablet%E2%80%90treated+diabetes+&author=C+Bradley&author=KS+Lewis&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0088"> <div class="reference-title-banner"> <h4 class="title">Bradley 1994</h4> </div> <div class="bibliography-section" id="CD003287-bib-0088"> <div class="citation-book">Bradley C. <span class="citation-title">A guide to psychological measurement in diabetes research and practice</span>. <span class="citation">Handbook of Psychology and Diabetes</span>. Routledge, <span class="pubYear">1994</span>. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+guide+to+psychological+measurement+in+diabetes+research+and+practice&author=C+Bradley&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0089"> <div class="reference-title-banner"> <h4 class="title">Brunelle 1998</h4> </div> <div class="bibliography-section" id="CD003287-bib-0089"> <div class="citation-journal">Brunelle RL, Llewelyn J, Anderson JH, Gale EAM, Koivisto VA. <span class="citation-title">Meta‐analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(10):1726‐31. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9773738" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Meta%E2%80%90analysis+of+the+effect+of+insulin+lispro+on+severe+hypoglycemia+in+patients+with+type+1+diabetes+&author=RL+Brunelle&author=J+Llewelyn&author=JH+Anderson&author=EAM+Gale&author=VA+Koivisto&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0090"> <div class="reference-title-banner"> <h4 class="title">Brunner 2000</h4> </div> <div class="bibliography-section" id="CD003287-bib-0090"> <div class="citation-journal">Brunner GA, Hirschberger S, Sendlhofer G, Wutte A, Ellmerer M, Balent B, et al. <span class="citation-title">Post‐prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2000</span>;<span class="volume">17</span>(5):371‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10872536" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Post%E2%80%90prandial+administration+of+the+insulin+analogue+insulin+aspart+in+patients+with+Type+1+diabetes+mellitus+&author=GA+Brunner&author=S+Hirschberger&author=G+Sendlhofer&author=A+Wutte&author=M+Ellmerer&author=B+Balent&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0091"> <div class="reference-title-banner"> <h4 class="title">Cohen 1960</h4> </div> <div class="bibliography-section" id="CD003287-bib-0091"> <div class="citation-journal">Cohen J. <span class="citation-title">A coefficient of agreement for nominal scales</span>. <span class="citation"> Educational and Psychological Measurement </span><span class="pubYear">1960</span>;<span class="volume">20</span>:37‐46. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+coefficient+of+agreement+for+nominal+scales&author=J+Cohen&publication_year=1960&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0092"> <div class="reference-title-banner"> <h4 class="title">Colquitt 2003</h4> </div> <div class="bibliography-section" id="CD003287-bib-0092"> <div class="citation-journal">Colquitt J, Royle P, Waugh N. <span class="citation-title">Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta‐analysis</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2003</span>;<span class="volume">20</span>:863‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14510870" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Are+analogue+insulins+better+than+soluble+in+continuous+subcutaneous+insulin+infusion?+Results+of+a+meta%E2%80%90analysis+&author=J+Colquitt&author=P+Royle&author=N+Waugh&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0093"> <div class="reference-title-banner"> <h4 class="title">Cox 1987</h4> </div> <div class="bibliography-section" id="CD003287-bib-0093"> <div class="citation-journal">Cox DJ, Irvine A, Gonder‐Frederick L, Nowaek G, Butterfield J. <span class="citation-title">Fear of hypoglycemia: quantification, validation and utilization</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1987</span>;<span class="volume">10</span>:617‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3677982" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Fear+of+hypoglycemia:+quantification,+validation+and+utilization&author=DJ+Cox&author=A+Irvine&author=L+Gonder%E2%80%90Frederick&author=G+Nowaek&author=J+Butterfield&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0094"> <div class="reference-title-banner"> <h4 class="title">Cryer 2002</h4> </div> <div class="bibliography-section" id="CD003287-bib-0094"> <div class="citation-journal">Cryer PE. <span class="citation-title">Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2002</span>;<span class="volume">45</span>:937‐48. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12136392" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Hypoglycaemia:+The+limiting+factor+in+the+glycaemic+management+of+Type+I+and+Type+II+diabetes+&author=PE+Cryer&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0095"> <div class="reference-title-banner"> <h4 class="title">Curtin 2002</h4> </div> <div class="bibliography-section" id="CD003287-bib-0095"> <div class="citation-journal">Curtin F, Altman DG, Elbourne DR. <span class="citation-title">Meta‐analysis combining parallel and cross‐over clinical trials I:continuous outcomes</span>. <span class="citation"> Statistics in medicine </span><span class="pubYear">2002</span>;<span class="volume">21</span>:2131‐44. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12210629" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Meta%E2%80%90analysis+combining+parallel+and+cross%E2%80%90over+clinical+trials+I:continuous+outcomes&author=F+Curtin&author=DG+Altman&author=DR+Elbourne&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0096"> <div class="reference-title-banner"> <h4 class="title">Davey 1997</h4> </div> <div class="bibliography-section" id="CD003287-bib-0096"> <div class="citation-journal">Davey P, Grainger D, MacMillan J, Rajan N, Aristides M, Gliksman M. <span class="citation-title">Clinical outcomes with insulin lispro compared with human regular insulin: a meta‐analysis</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">1997</span>;<span class="volume">19</span>(4):656‐74. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9377611" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+outcomes+with+insulin+lispro+compared+with+human+regular+insulin:+a+meta%E2%80%90analysis&author=P+Davey&author=D+Grainger&author=J+MacMillan&author=N+Rajan&author=M+Aristides&author=M+Gliksman&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0097"> <div class="reference-title-banner"> <h4 class="title">DCCT 1988</h4> </div> <div class="bibliography-section" id="CD003287-bib-0097"> <div class="citation-journal">The DCCT Research Group. <span class="citation-title">Reliability and validity of a diabetes quality‐of‐life for the diabetes control and complications trial</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1988</span>;<span class="volume">11</span>:725‐32. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3066604" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0098"> <div class="reference-title-banner"> <h4 class="title">DCCT 1991</h4> </div> <div class="bibliography-section" id="CD003287-bib-0098"> <div class="citation-journal">The DCCT Research Group. <span class="citation-title">Epidemiology of severe hypoglycemia in the diabetes control and complications Trial</span>. <span class="citation"> The American journal of medicine </span><span class="pubYear">1991</span>;<span class="volume">90</span>:450‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2012085" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0099"> <div class="reference-title-banner"> <h4 class="title">DCCT 1993</h4> </div> <div class="bibliography-section" id="CD003287-bib-0099"> <div class="citation-journal">The Diabetes Control and Complications Trial Research Group. <span class="citation-title">The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus</span>. <span class="citation"> The New England journal of medicine </span><span class="pubYear">1993</span>;<span class="volume">329</span>:977‐86. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8366922" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0100"> <div class="reference-title-banner"> <h4 class="title">Elbourne 2002</h4> </div> <div class="bibliography-section" id="CD003287-bib-0100"> <div class="citation-journal">Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. <span class="citation-title">Meta‐analysis involving cross‐over trials: methological issues</span>. <span class="citation"> International journal of epidemiology </span><span class="pubYear">2002</span>;<span class="volume">31</span>:140‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11914310" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Meta%E2%80%90analysis+involving+cross%E2%80%90over+trials:+methological+issues&author=DR+Elbourne&author=DG+Altman&author=JPT+Higgins&author=F+Curtin&author=HV+Worthington&author=A+Vail&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0101"> <div class="reference-title-banner"> <h4 class="title">Gerstein 2001</h4> </div> <div class="bibliography-section" id="CD003287-bib-0101"> <div class="citation-book">Gerstein HC, Haynes RB. <span class="citation">Evidence‐based diabetes care</span>. Hamilton: BC Decker Inc, <span class="pubYear">2001</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0102"> <div class="reference-title-banner"> <h4 class="title">Grant 1993</h4> </div> <div class="bibliography-section" id="CD003287-bib-0102"> <div class="citation-journal">Grant MB, Mames RN, Fitzgerald C, Ellis EA, Aboufrikha M, Guy J. <span class="citation-title">Insulin‐like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1993</span>;<span class="volume">36</span>:282‐91. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7682976" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin%E2%80%90like+growth+factor+I+acts+as+an+angiogenic+agent+in+rabbit+cornea+and+retina:+comparative+studies+with+basic+fibroblast+growth+factor+&author=MB+Grant&author=RN+Mames&author=C+Fitzgerald&author=EA+Ellis&author=M+Aboufrikha&author=J+Guy&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0103"> <div class="reference-title-banner"> <h4 class="title">Haffner 1998</h4> </div> <div class="bibliography-section" id="CD003287-bib-0103"> <div class="citation-journal">Haffner SM. <span class="citation-title">The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease</span>. <span class="citation"> Endocrine Reviews </span><span class="pubYear">1998</span>;<span class="volume">19</span>(5):583‐92. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9793758" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+importance+of+hyperglycemia+in+the+nonfasting+state+to+the+development+of+cardiovascular+disease+&author=SM+Haffner&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0104"> <div class="reference-title-banner"> <h4 class="title">Heinemann 1995</h4> </div> <div class="bibliography-section" id="CD003287-bib-0104"> <div class="citation-journal">Heinemann L. <span class="citation-title">Do insulin‐treated diabetic patients use an injection‐meal‐interval in daily life?</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1995</span>;<span class="volume">12</span>(5):449‐50. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7648813" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Do+insulin%E2%80%90treated+diabetic+patients+use+an+injection%E2%80%90meal%E2%80%90interval+in+daily+life?&author=L+Heinemann&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0105"> <div class="reference-title-banner"> <h4 class="title">Heinemann 1996</h4> </div> <div class="bibliography-section" id="CD003287-bib-0105"> <div class="citation-journal">Heinemann L, Kapitza C, Starke AAR, Heise T. <span class="citation-title">Time‐action profile of the insulin analogue B28Asp</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1996</span>;<span class="volume">13</span>:683‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8840108" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Time%E2%80%90action+profile+of+the+insulin+analogue+B28Asp&author=L+Heinemann&author=C+Kapitza&author=AAR+Starke&author=T+Heise&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0106"> <div class="reference-title-banner"> <h4 class="title">Higgins 2005</h4> </div> <div class="bibliography-section" id="CD003287-bib-0106"> <div class="citation-other">Higgins JPT, Green S, editors. <span class="citation-title">Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]</span>. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley &amp; Sons, Ltd. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0107"> <div class="reference-title-banner"> <h4 class="title">Homko 2003</h4> </div> <div class="bibliography-section" id="CD003287-bib-0107"> <div class="citation-journal">Homko C, Deluzio A, Jimenez C, Kolaczynski JW, Boden G. <span class="citation-title">Comparison of insulin aspart and lispro</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>:2027‐31. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12832307" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+insulin+aspart+and+lispro&author=C+Homko&author=A+Deluzio&author=C+Jimenez&author=JW+Kolaczynski&author=G+Boden&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0108"> <div class="reference-title-banner"> <h4 class="title">Howey 1994</h4> </div> <div class="bibliography-section" id="CD003287-bib-0108"> <div class="citation-journal">Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. <span class="citation-title">[Lys(B28),Pro(B29)]‐human insulin A rapidly absorbed analogue of human insulin</span>. <span class="citation"> Diabetes </span><span class="pubYear">1994</span>;<span class="volume">43</span>:396‐402. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8314011" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Lys(B28),Pro(B29)]%E2%80%90human+insulin+A+rapidly+absorbed+analogue+of+human+insulin&author=DC+Howey&author=RR+Bowsher&author=RL+Brunelle&author=JR+Woodworth&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0109"> <div class="reference-title-banner"> <h4 class="title">Jadad 1996</h4> </div> <div class="bibliography-section" id="CD003287-bib-0109"> <div class="citation-journal">Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. <span class="citation-title">Assessing the quality of reports of randomized clinical trials: is blinding necessary?</span>. <span class="citation"> Controlled Clinical Trials </span><span class="pubYear">1996</span>;<span class="volume">17</span>(1):1‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8721797" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Assessing+the+quality+of+reports+of+randomized+clinical+trials:+is+blinding+necessary?&author=AR+Jadad&author=RA+Moore&author=D+Carroll&author=C+Jenkinson&author=DJM+Reynolds&author=DJ+Gavaghan&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0110"> <div class="reference-title-banner"> <h4 class="title">Jørgensen 1992</h4> </div> <div class="bibliography-section" id="CD003287-bib-0110"> <div class="citation-journal">Jørgensen LN, Didriksen LH, Drejer K. <span class="citation-title">Carciogen effect of the human insulin analogue B10 Asp in female rats</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1992</span>;<span class="volume">35 Suppl 1</span>:A3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Carciogen+effect+of+the+human+insulin+analogue+B10+Asp+in+female+rats&author=LN+J%C3%B8rgensen&author=LH+Didriksen&author=K+Drejer&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0111"> <div class="reference-title-banner"> <h4 class="title">Kadiri 2001</h4> </div> <div class="bibliography-section" id="CD003287-bib-0111"> <div class="citation-journal">Kadiri A, Al Nakhi A, Ghazali S, Jabbar A, Al Arouj M, Akram J, et al. <span class="citation-title">Treatment of type 1 diabetes with insulin lispro during Ramadan</span>. <span class="citation"> Diabetes Metabolism </span><span class="pubYear">2001</span>;<span class="volume">27</span>:482‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11547222" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+of+type+1+diabetes+with+insulin+lispro+during+Ramadan&author=A+Kadiri&author=A+AlNakhi&author=S+Ghazali&author=A+Jabbar&author=M+AlArouj&author=J+Akram&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0112"> <div class="reference-title-banner"> <h4 class="title">King 1985</h4> </div> <div class="bibliography-section" id="CD003287-bib-0112"> <div class="citation-journal">King GL, Goodman AD, Buzney S, Moses A, Kahn CR. <span class="citation-title">Receptors and growth‐promoting effects of insulin and insulin‐like growth factors on cells from bovine retinal capillaries and aorta</span>. <span class="citation"> Journal of Clinical Investigation </span><span class="pubYear">1985</span>;<span class="volume">75</span>:1028‐36. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2984251" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Receptors+and+growth%E2%80%90promoting+effects+of+insulin+and+insulin%E2%80%90like+growth+factors+on+cells+from+bovine+retinal+capillaries+and+aorta+&author=GL+King&author=AD+Goodman&author=S+Buzney&author=A+Moses&author=CR+Kahn&publication_year=1985&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0113"> <div class="reference-title-banner"> <h4 class="title">Kurtzhals 2000</h4> </div> <div class="bibliography-section" id="CD003287-bib-0113"> <div class="citation-journal">Kurtzhals P, Schäffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C, et al. <span class="citation-title">Correlation of receptor binding and metabolic and metogenic potencies of insulin analogues designed for clinical use</span>. <span class="citation"> Diabetes </span><span class="pubYear">2000</span>;<span class="volume">49</span>:999‐1005. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10866053" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Correlation+of+receptor+binding+and+metabolic+and+metogenic+potencies+of+insulin+analogues+designed+for+clinical+use+&author=P+Kurtzhals&author=L+Sch%C3%A4ffer&author=A+Sorensen&author=C+Kristensen&author=I+Jonassen&author=C+Schmid&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0114"> <div class="reference-title-banner"> <h4 class="title">Marshall 1999</h4> </div> <div class="bibliography-section" id="CD003287-bib-0114"> <div class="citation-book">Marshall SM, Home PD, Rizza RA. <span class="citation">The diabetes annual 12</span>. Elsevier Science Ltd, <span class="pubYear">1999</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0115"> <div class="reference-title-banner"> <h4 class="title">Martin 1994</h4> </div> <div class="bibliography-section" id="CD003287-bib-0115"> <div class="citation-journal">Martin JM, Anderson DM, UK Lispro Study Group. <span class="citation-title">A short‐acting insulin analogue in clinical practice</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1994</span>;<span class="volume">11</span>(3):35 (Abstract). <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+short%E2%80%90acting+insulin+analogue+in+clinical+practice&author=JM+Martin&author=DM+Anderson&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0116"> <div class="reference-title-banner"> <h4 class="title">Mosekilde 1989</h4> </div> <div class="bibliography-section" id="CD003287-bib-0116"> <div class="citation-journal">Mosekilde E, Skovbo JK, Binder C, Pramming S, Thorsteinsson B. <span class="citation-title">Modeling absorption kinetics of subcutaneous injected soluble insulin</span>. <span class="citation"> Journal of Pharmacokinetics and Biopharmaceutics </span><span class="pubYear">1989</span>;<span class="volume">17</span>(1):67‐87. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2654357" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Modeling+absorption+kinetics+of+subcutaneous+injected+soluble+insulin&author=E+Mosekilde&author=JK+Skovbo&author=C+Binder&author=S+Pramming&author=B+Thorsteinsson&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0117"> <div class="reference-title-banner"> <h4 class="title">Muehlhauser 1998</h4> </div> <div class="bibliography-section" id="CD003287-bib-0117"> <div class="citation-journal">Muehlhauser I, Overmann H, Bender R, Bott U, Berger M. <span class="citation-title">Risk factors of severe hypoglycaemia in adult patients with Type 1 diabetes ‐ a prospective population based study</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1998</span>;<span class="volume">41</span>:1274‐82. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9833933" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Risk+factors+of+severe+hypoglycaemia+in+adult+patients+with+Type+1+diabetes+%E2%80%90+a+prospective+population+based+study+&author=I+Muehlhauser&author=H+Overmann&author=R+Bender&author=U+Bott&author=M+Berger&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0118"> <div class="reference-title-banner"> <h4 class="title">Plank 2002</h4> </div> <div class="bibliography-section" id="CD003287-bib-0118"> <div class="citation-journal">Plank J, Wutte A, Brunner G, Siebenhofer A, Semlitsch B, Sommer R, et al. <span class="citation-title">A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>:2053‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12401756" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+direct+comparison+of+insulin+aspart+and+insulin+lispro+in+patients+with+type+1+diabetes&author=J+Plank&author=A+Wutte&author=G+Brunner&author=A+Siebenhofer&author=B+Semlitsch&author=R+Sommer&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0119"> <div class="reference-title-banner"> <h4 class="title">Pramming 1990</h4> </div> <div class="bibliography-section" id="CD003287-bib-0119"> <div class="citation-journal">Pramming S, Thorsteinsson B, Bendtson I, Binder C. <span class="citation-title">The relationship between symptomatic and biochemical hypoglycemia in insulin‐dependent diabetic patients</span>. <span class="citation"> The Journal of international medical research </span><span class="pubYear">1990</span>;<span class="volume">228</span>:641‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+relationship+between+symptomatic+and+biochemical+hypoglycemia+in+insulin%E2%80%90dependent+diabetic+patients+&author=S+Pramming&author=B+Thorsteinsson&author=I+Bendtson&author=C+Binder&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0120"> <div class="reference-title-banner"> <h4 class="title">Ronnemaa 1998</h4> </div> <div class="bibliography-section" id="CD003287-bib-0120"> <div class="citation-journal">Ronnemaa T, Viikari J. <span class="citation-title">Reducing snacks when switching from conventional soluble to lispro insulin treatment: Effects on glycaemic control and hypoglycaemia</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1998</span>;<span class="volume">15</span>(7):601‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9686701" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Reducing+snacks+when+switching+from+conventional+soluble+to+lispro+insulin+treatment:+Effects+on+glycaemic+control+and+hypoglycaemia+&author=T+Ronnemaa&author=J+Viikari&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0121"> <div class="reference-title-banner"> <h4 class="title">Schernthaner 1998</h4> </div> <div class="bibliography-section" id="CD003287-bib-0121"> <div class="citation-journal">Schernthaner G, Wein W, Sandholzer K, Equiluz‐Bruck S, Bates PC, Birkett MA. <span class="citation-title">Postprandial insulin lispro: a new therapeutic option for type 1 diabetic patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(4):570‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9571344" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Postprandial+insulin+lispro:+a+new+therapeutic+option+for+type+1+diabetic+patients&author=G+Schernthaner&author=W+Wein&author=K+Sandholzer&author=S+Equiluz%E2%80%90Bruck&author=PC+Bates&author=MA+Birkett&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0122"> <div class="reference-title-banner"> <h4 class="title">Schulz 1995</h4> </div> <div class="bibliography-section" id="CD003287-bib-0122"> <div class="citation-journal">Schulz KF, Chalmers I, Hayes RJ, Altman DG. <span class="citation-title">Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials</span>. <span class="citation"> Journal of the American Medical Association </span><span class="pubYear">1995</span>;<span class="volume">273</span>(5):408‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7823387" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Empirical+evidence+of+bias:+dimensions+of+methodological+quality+associated+with+estimates+of+treatment+effects+in+controlled+trials+&author=KF+Schulz&author=I+Chalmers&author=RJ+Hayes&author=DG+Altman&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0123"> <div class="reference-title-banner"> <h4 class="title">Shukla 1999</h4> </div> <div class="bibliography-section" id="CD003287-bib-0123"> <div class="citation-other">Shukla V K, Otten N. <span class="citation-title">Insulin lispro: A critical evaluation</span>. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 1999. Report No.: 18. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0124"> <div class="reference-title-banner"> <h4 class="title">Torlone 1994</h4> </div> <div class="bibliography-section" id="CD003287-bib-0124"> <div class="citation-journal">Torlone E, Fanelli C, Rambotti AM, Kassi G, Modarelli F, Vicenzo A, et al. <span class="citation-title">Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1994</span>;<span class="volume">37</span>(7):713‐20. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7958544" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pharmacokinetics,+pharmacodynamics+and+glucose+counterregulation+following+subcutaneous+injection+of+the+monomeric+insulin+analogue+[Lys(B28),Pro(B29)]+in+IDDM+&author=E+Torlone&author=C+Fanelli&author=AM+Rambotti&author=G+Kassi&author=F+Modarelli&author=A+Vicenzo&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0125"> <div class="reference-title-banner"> <h4 class="title">WHO 1985</h4> </div> <div class="bibliography-section" id="CD003287-bib-0125"> <div class="citation-other">World Health Organisation. <span class="citation-title">Diabetes mellitus. Report of a WHO Study Group</span>. WHO Technical Report Series; 1985. Report No.: 727. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD003287-bbs2-0126"> <div class="reference-title-banner"> <h4 class="title">Zinman 1989</h4> </div> <div class="bibliography-section" id="CD003287-bib-0126"> <div class="citation-journal">Zinman B. <span class="citation-title">The physiological replacement of insulin: An elusive goal</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1989</span>;<span class="volume">321</span>(6):363‐70. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2664524" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+physiological+replacement+of+insulin:+An+elusive+goal&author=B+Zinman&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD003287-sec2-0016"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD003287-sec2-0017" class="jump-to">excluded studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Altuntas 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: single centre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT:‐ BLINDING: open <br> ITT: unclear <br> SPONSOR: not defined <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Turkey <br> NUMBER: 40 <br> TYPE OF DIABETES: 2 <br> MEAN AGE [YEARS]: 55 <br> MEAN DIABETES DURATION [YEARS]: 6 vs 10 (lispro vs. regular) <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 168 <br> SCHEDULE: analogue: immediately; regular: 30 ‐ 45 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]:‐ <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3.3 mmol/l or symptoms <br> OUTCOME 0.57% vs. 0,009% (lispro vs. regular); reference base unclear) <br> 3. HYPOGLYCAEMIA : SEVERE <br> DEFINITION: ‐ <br> OUTCOME: ‐ <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described ‐ none <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c was not shown because of inconsistent baseline HbA1c data</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Anderson 1997a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre, multinational <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear BLINDING: open <br> ITT: unclear <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: AMERICA, EUROPE, AUSTRALIA, South Africa <br> NUMBER: 722 <br> TYPE OF DIABETES: 2 <br> MEAN AGE [YEARS]: 59 <br> MEAN DIABETES DURATION [YEARS]: 12 <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 90 <br> SCHEDULE: analogue: immediately; regular: 30 ‐ 45 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 8.2 vs. 8.2 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3.5 mmol/l and/or symptoms <br> OUTCOME[epis/pat/month]: 3.2 vs. 3.4 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA : SEVERE <br> DEFINITION: iv glucose or glucagon <br> OUTCOME [overall episodes]: 1 vs. 5 (lispro vs regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Anderson 1997b </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre, multinational <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: AMERICA, EUROPE, AUSTRALIA ,South Africa <br> NUMBER: 1008 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 33 <br> MEAN DIABETES DURATION [YEARS]: 12 <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 90 <br> SCHEDULE: lispro: immediately; regular: 30‐45 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 8.2 vs. 8.2 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt;3.5 mmol/l and/or symptoms <br> OUTCOME [epis/pat/month]: 6.4 vs 7.2 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: 84 vs. 119 (lispro vs regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Anderson 1997c </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: multicentre, multinational <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: AUSTRALIA, USA, CANADA, EUROPE, South Africa <br> NUMBER: I:Type 1: 162 vs. 174; II:Type 2: 145 vs. 150 Type 2 (lispro vs. regular) <br> TYPE OF DIABETES: 1 and 2 <br> MEAN AGE [YEARS]: Type 1: 32 vs. 32; Type 2: 56 vs. 56 (lispro vs. regular) <br> MEAN DIABETES DURATION [YEARS]: Type 1: 13 vs. 12; Type 2: 12 vs. 12 (lispro vs. regular) <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 360 <br> SCHEDULE: lispro: immediately vs. regular: 30 to 45 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: Type 1: 8.1 vs. 8.3; Type 2: 8.2 vs 8.4 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 2 mmol/l and/or symptoms <br> OUTCOME [epis/pat/month]: TYPE 1: 4.4 vs. 4.5; Type 2: 1.5 vs. 1.6 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: not defined <br> OUTCOME: not reported <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Annuzzi 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: adequate <br> ALLOCATION CONCEALMENT: adequate <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> NUMBER: 90 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 31 <br> MEAN DIABETES DURATION [YEARS]: 12 <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 90 <br> SCHEDULE: lispro: immediately; regular: 30‐45 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 8.1 vs. 8.3 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3.3 mmol/l and/or symptoms <br> OUTCOME [epis/pat/month]: 3.0 vs. 2.4 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: 4 vs. 6 (lispro vs. regular) <br> 4. QUALITY OF LIFE: <br> Preference for lispro shown by DTSQ data. <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bode 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: single centre <br> RANDOMISATION PROCEDURE: adequate <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR:Novo Nordisk <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: USA <br> NUMBER: 19 vs. 10 (aspart vs. regular) <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 38 vs. 34 (aspart vs. regular) <br> MEAN DIABETES DURATION [YEARS]: ‐ <br> OTHER CHARACTERISTICS: patients on CSII therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>ASPART VERSUS REGULAR: <br> LENGTH OF INTERVENTION [days]: 49 days <br> SCHEDULE: aspart: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 6.9 vs. 7.1 (aspart vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 2.5 mmol/l without an appropriate explanation <br> OUTCOME [patients with episodes]: 14 vs. 6 (aspart vs. regular) <br> 3. HYPOGLYCAEMA: SEVERE <br> DEFINITION: not defined <br> OUTCOME: not reported <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 7. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bode 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: adequate <br> ALLOCATION CONCEALMENT: unclear BLINDING: open <br> ITT: unclear <br> SPONSOR: Novo Nordisk <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: USA <br> NUMBER: 59 vs. 59 vs. 28 (aspart (I) vs. regular vs.lispro (II)) <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 42 vs. 43 vs. 40 (aspart vs. regular vs.lispro) <br> MEAN DIABETES DURATION [YEARS]: ‐ <br> OTHER CHARACTERISTICS: patients on CSII therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>ASPART (I) VERSUS REGULAR [VERSUS LISPRO (II)] <br> LENGTH OF INTERVENTION [days]: 112 <br> SCHEDULE: aspart and lispro: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: no significant difference <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: symptoms <br> OUTCOME [overall episodes]: 1580 vs. 2240 vs. 1159 (aspart vs. regular vs. lispro) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: &lt; 2.8 mmol/l and third party help <br> OUTCOME [overall episodes]: 0 vs.1 vs.0 (aspart vs. regular vs. lispro) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Boehm 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: multicentre, multinational <br> RANDOMISATION PROCEDURE: adaequate <br> ALLOCATION CONCEALMENT: adaequate <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: Novo Nordisk <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany, Austria, UK, Ireland <br> NUMBER: Type 1: 55 vs. 49; Type 2: 85 vs. 102 (premixed formulation of aspart[BiAsp 30] vs. premixed formulation of regular [BHI 30]) <br> TYPE OF DIABETES: 1 and 2 <br> MEAN AGE [YEARS]: Type 1: 43 vs. 46; Type 2: 63 vs. 64 (BiAsp 30 vs. BHI 30) <br> MEAN DIABETES DURATION [YEARS]: Type 1: 15 vs. 17; Type 2: 15 vs. 14 (BiAsp 30 vs. BHI 30) <br> OTHER CHARACTERISTICS:‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>BiAsp 30 VERSUS BHI 30 <br> LENGTH OF INTERVENTION [days]: 84 <br> SCHEDULE: BiAsp 30: 10 min.; BHI 30: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint type 1 and type 2: 8.1 vs. 8.2 (BiAsp 30 vs. BHI 30) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: symptoms <br> OUTCOME [overall episodes]: Type 1 and Type 2: 382 vs. 403 (BiAsp 30 vs. BHI 30) <br> Type 1: 121 vs. 115 (BiAsp 30 vs. BHI 30) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: Type 1 and Type 2: 20 vs. 42 (BiAsp 30 vs. BHI 30) <br> Type 1: 4 vs.14 (BiAsp 30 vs. BHI 30) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> ‐ <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Pharmacy dispensing error</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bott 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: Novo Nordisk <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Austria, Germany, Switzerland <br> NUMBER: 283 vs. 141 (aspart vs. regular) <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 37 <br> MEAN DIABETES DURATION [YEARS]: 13 <br> OTHER CHARACTERISTICS: ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>ASPART VERSUS REGULAR: LENGTH OF INTERVENTION [days]: 180 SCHEDULE: aspart: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 7.5 vs. 7.5 (aspart vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: symptoms <br> OUTCOME: no difference <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: no difference <br> 4. QUALITY OF LIFE: <br> significant change from baseline in favour of aspart for DSQOLS and DTSQ score <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> ‐ <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Part results of german speaking participants of HOME 2000</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bretzel 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: yes and per protocol <br> SPONSOR: Novo Nordisk <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> NUMBER: 75 vs. 80 (aspart vs. regular) <br> TYPE OF DIABETES: 2 <br> MEAN AGE [YEARS]: 61‐62 <br> MEAN DIABETES DURATION [YEARS]: ‐ <br> OTHER CHARACTERISTICS: ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>ASPART VERSUS REGULAR: LENGTH OF INTERVENTION [days]: 84 SCHEDULE: aspart and regular: preprandial </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: ‐ <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt;2.5 mmol/l and/or symptoms <br> OUTCOME: [ep/pat/month]: 0.4 vs. 0.56 (aspart vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: ‐ <br> OUTCOME.‐ <br> 4. QUALITY OF LIFE: ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> numbers given, no reason described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>no randomisation HbA1c; <br> third study arm no comparable intervention </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Chan 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: cross‐over <br> SETTING: unclear <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: not defined <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: China <br> NUMBER: Type 1: 12; Type 2: 18 <br> TYPE OF DIABETES: 1 and 2 <br> MEAN AGE [YEARS]: Type 1 and Type 2: mean 42 years <br> MEAN DIABETES DURATION [YEARS]: Type 1 and Type 2: 8 years <br> OTHER CHARACTERISTICS:‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 84 <br> SCHEDULE: lispro and regular: time not reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: <br> Type 1: 6,8 vs. 6,6 (lispro vs. regular) <br> Type 2: 7,6 vs. 7,6 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: <br> OUTCOME: &lt; 3.0 mmol/l and/or symptoms[ep/pat/month]: Type 1 and Type 2: <br> 50 vs. 38 (lispro vs. regular) <br> HYPOGLYCAEMIA: SEVERE <br> DEFINITION: TPH <br> OUTCOME [overall episodes]: Type 1 and Type 2: <br> 2 vs. 1 (lispro vs. regular) <br> 4. QUALITY OF LIFE: ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ciofetta 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel, group 1 and 2 included <br> SETTING: single centre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: not defined <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> NUMBER : 8 vs.8 (lispro vs. regular) <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 33 <br> MEAN DIABETES DURATION [YEARS]: 13 <br> OTHER CHARACTERISTICS:‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 90 <br> SCHEDULE: lispro: immediately; regular: 10‐40 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 7.0 vs. 6.8 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3.9 mmol/l <br> OUTCOME [epis/pat/month]: 8.1 vs. 4.0 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall epidodes]: lispro and regular: 0 <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.FOLLOW UP: <br> not described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Deeb 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: 3‐period crossover <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: USA, Canada <br> NUMBER: 60 <br> TYPE OF DIABETES: 1 <br> AGE [YEARS]: 8 <br> MEAN DIABETES DURATION [YEARS]: 4 <br> OTHER CHARACTERISTICS:‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO PREPRANDIAL VERSUS LISPRO POSTPRANDIAL VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 90 <br> SCHEDULE: lispro preprandial: 0‐15 min.; lispro postprandial: directly after meals; regular: 30‐45 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 8.4 vs. 8.5 vs. 8.4 (lispro preprandial vs. lispro postprandial vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt;3,5 mmol/l and/or symptoms <br> OUTCOME [epis/pat/month]: 14.7 vs. 13.6 vs. 13.8 (lispro preprandial vs. lispro postprandial vs. regular) <br> 3. HYPOGLYCEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: 2 vs. 3 vs. 6 (lispro preprandial vs. lispro postprandial vs. regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Del Sindaco 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover, 2 (I,II) of 4 comparison groups included SETTING: single centre RANDOMISATION PROCEDURE: unclear ALLOCATION CONCEALMENT: unclear BLINDING: open ITT: unclear SPONSOR: not defined QUALITY ASSESSMENT: C </p> <p>Comparison II used for analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy NUMBER: I: 15 ; II: 12 TYPE OF DIABETES: 1 MEAN AGE [YEARS]: I:33; II: 32 MEAN DIABETES DURATION [YEARS]: I: 15; II: 13 OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>I: LISPRO+1‐2x NPH VERSUS REGULAR+1‐2x NPH; II: LISPRO+3‐4x NPH VERSUS REGULAR+3‐4x NPH LENGTH OF INTERVENTION [days]: 90 SCHEDULE: lispro: immediately ; regular: 10 ‐ 40 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: I: at endpoint: no significant difference II: at endpoint: significant difference in favor of lispro 2. HYPOGLYCAEMIA: OVERALL DEFINITION: &lt; 3.3 mmol OUTCOME [epis/pat/month]: I: 5.3 vs. 4.0; II: 4.4 vs. 11 3. HYPOGLYCAEMIA: SEVERE DEFINITION: third party help OUTCOME [overall episodes]: I+II: 0 4. QUALITY OF LIFE: ‐ 5. ADVERSE EVENTS: ‐ 6.COSTS: ‐ 7.DROP OUTS: not described 8. OTHERS: ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ferguson 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: single centre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: no <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: UK <br> NUMBER: 39 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 46 <br> MEAN DIABETES DURATION [YEARS]: 26 <br> OTHER CHARACTERISTICS: patients with impaired hypoglycemia awareness, patients on multiple injections and twice daily insulin therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 168 <br> SCHEDULE: lispro: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 9.1 vs. 9.3 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: 3.5 mmol/l and/or symptoms <br> OUTCOME [overall episodes]: 1156 vs. 1115 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: 55 vs. 84 (lispro vs. regular) <br> 4. QUALITY OF LIFE: <br> DTSQ and HFS: no significant difference <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described, post hoc exclusion of 1 patient <br> 8. OTHERS <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ford‐Adams 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: adequate <br> BLINDING: open <br> ITT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: B </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: UK <br> NUMBER: 23 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [years]: 9 <br> MEAN DIABETES DURATION [years]: not known <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 112 <br> SCHEDULE: not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: no significant difference <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: symptoms <br> OUTCOME [overall episodes]: 556 vs. 604 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA : SEVERE <br> DEFINITION: convulsions and/or glucagon <br> OUTCOME [overall episodes]: 2 vs. 1 (lispro vs. regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7. DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gale 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: double‐blind <br> IIT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: UK <br> NUMBER: 93 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 35 <br> MEAN DIABETES DURATION [YEARS]: 13 <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 84 <br> SCHEDULE: lispro and regular: immediately </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: at endpoint: 7,5% vs. 7,4% (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: ‐ <br> OUTCOME:‐ <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: coma and/or iv glucose or glucagon <br> OUTCOME [overall episodes]: 3 vs. 10 (lispro vs. regular) <br> 4. QUALITY OF LIFE: no significant difference in DTSQ, WBQ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7. DROP OUTS: <br> described <br> 8. OTHERS <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gallagher 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: single centre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: third party contact <br> BLINDING: double‐blind <br> IIT: unclear <br> SPONSOR: NOVO Nordisk <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: UK <br> NUMBER: 21 <br> TYPE OF DIABETES: 2 <br> MEAN AGE [YEARS]: 66 <br> MEAN DIABETES DURATION [YEARS]: 11 <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>ASPART VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 42 <br> SCHEDULE: aspart and regular: 5 minutes before meals </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 7.0 vs. 7.2 (aspart vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION:‐ <br> OUTCOME <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION:‐ <br> OUTCOME: 0 in both groups <br> 4. QUALITY OF LIFE: ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7. DROP OUTS: described ‐ unclear if patients were withdrawn before of after randomisation <br> 8. OTHERS </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>personal communication: <br> no severe hypoglycaemic episodes </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Garg 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> IIT: yes <br> SPONSOR: Sanofi‐Aventis <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: USA <br> NUMBER: 286 vs. 296 vs. 278 (glu premeal vs. glu postmeal vs. regular) <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 41 vs. 40 vs. 40 (glu premeal vs. glu postmeal vs. regular) <br> MEAN DIABETES DURATION [YEARS]: 20 vs. 20 vs. 19 (glu premeal vs. glu postmeal vs. regular) <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>GLULISINE PREMEAL VERSUS GLULISINE <br> POSTMEAL VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 84 <br> SCHEDULE: <br> glulisine premeal: 0‐15 <br> minutes; glulisine postmeal: immediately after completing, or 20 minutes after starting the meal; regular: 30 ‐ 45 minutes </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1. HBA1C [%]: change from baseline to endpoint: ‐0.26% <br> vs. ‐0.11% vs.‐0.13% (glu premeal vs. glu postmeal vs. regular)2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: symptoms <br> OUTCOME: [epis/pat/month] 3,5 vs. 3.7 vs. 3.5 (glu premeal vs. glu postmeal vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: TPH <br> OUTCOME: [epis/pat/month] 0.05 vs. 0.05 vs. 0.13 (glu premeal vs. glu postmeal vs. regular) <br> 4. QUALITY OF LIFE: ‐ <br> 5. ADVERSE EVENTS: described <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7. DROP OUTS:described, but not separately for the treatment groups. <br> OTHERS: ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hedman 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: single centre <br> RANDOMISATION PROCEDURE: adequate <br> ALLOCATION CONCEALMENT: adequate <br> BLINDING: open <br> IIT: yes <br> SPONSOR: not defined <br> QUALITY ASSESSMENT: B </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> NUMBER: 12 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 48 <br> MEAN DIABETES DURATION [YEARS]: 31 <br> OTHER CHARACTERISTICS: patients on CSII therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION[days]: 42 <br> SCHEDULE: lispro: immediately; regular: 20 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: at endpoint <br> 7,7 vs. 7,7 (aspart vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: ‐ <br> OUTCOME: ‐ <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: lispro and regular: 0 <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Heller 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover designed, <br> only first treament period because of period and treatment period interactions analyzed <br> SETTING: multicentre <br> RANDOMIZATION PROCEDURE: adequate ALLOCATION CONCEALMENT: adequate <br> BLINDING: open <br> ITT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: B </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: UK <br> NUMBER: 68 vs. 67 (lispro vs. regular) <br> TYPE OF DIABETES:1 <br> MEAN AGE [YEARS]: 37 vs. 39 (lispro vs. regular) <br> MEAN DIABETES DURATION [YEARS]: 16 vs. 17(lispro vs. regular) <br> OTHER CHARACTERISTICS:‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 120 <br> SCHEDULE: lispro: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint of period 1: 6.0 vs. 6.2 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL‐Period 1 <br> DEFINITION: &lt;3mmol/l and/or symptoms <br> OUTCOME [overall epidoses]: 724 vs. 1072 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE‐Period 1 <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: 8 vs. 12 (lispro vs. regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> 1 patient died after prolonged seizure that was possible related to hypoglycaemia during the second phase of the study <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8.OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Heller 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover SETTING: multicentre <br> RANDOMIZATION PROCEDURE: adequate ALLOCATION CONCEALMENT: adequate <br> BLINDING: double‐blind <br> ITT: no <br> SPONSOR: Novo Nordisk <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: UK <br> NUMBER: 156 <br> TYPE OF DIABETES:1 <br> MEAN AGE [YEARS]: 36 <br> MEAN DIABETES DURATION [YEARS]: ‐ <br> OTHER CHARACTERISTICS:‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>ASPART VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 112 <br> SCHEDULE: aspart and regular: immediately before meals </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint 7,7 vs. 7,7 (aspart vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: symptoms <br> OUTCOME <br> 3. [ep/pat/year]: 35,8 vs. 38,2 (aspart vs. regular) <br> HYPOGLYCAEMIA: SEVERE‐ DEFINITION: third party help <br> OUTCOME: [ep/pat/year]: 0,85 vs. 1,12 (aspart vs. regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: </p> <p>6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> unclear <br> 8.OTHERS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Discrepancies in reporting of major nocturnal hypoglycaemia within publication and between congress posters and publication. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Herz 2002a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: single centre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Croatia <br> NUMBER: 37 <br> TYPE OF DIABETES: 2 <br> MEAN AGE [YEARS]: 55 vs. 56 (premixed formuation of lispro [Mix 25]‐premixed formulation of regular [BHI 30] vs. BHI 30‐Mix 25 treatment sequence <br> MEAN DIABETES DURATION [YEARS]: 8.9 vs. 7.5 (Mix 25‐BHI 30 vs. BHI 30 ‐ Mix 25 treatment sequence) <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>MIX 25 VERSUS BHI 30 <br> LENGTH OF INTERVENTION [days]: 28 <br> SCHEDULE: MIX 25: 5 min.; BHI 30: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> ‐ <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt;3 mmol/l and/or symptoms <br> OUTCOME [pat/month]: 0.7 vs. 1.2 (Mix 25 vs. BHI 30) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: ‐ <br> OUTCOME: ‐ <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Herz 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover SETTING: single centre RANDOMISATION PROCEDURE: unclear ALLOCATION CONCEALMENT: unclear BLINDING: open ITT: yes SPONSOR: Eli Lilly QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: South Africa NUMBER: 25 TYPE OF DIABETES: 2 MEAN AGE [YEARS]: 55 vs. 54 (premixed formuation of lispro [Mix 25]‐premixed formulation of regular [BHI 30] vs. BHI 30‐Mix 25 treatment sequence MEAN DIABETES DURATION [YEARS]: ‐ OTHER CHARACTERISTICS: ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>MIX 25 VERSUS BHI 30 LENGTH OF INTERVENTION [days]: 28 SCHEDULE: MIX 25: 5 min.; BHI 30: 5 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: ‐ 2. HYPOGLYCAEMIA: OVERALL DEFINITION: &lt;3 mmol/l and/or symptoms OUTCOME [epis/pat/month]: 0.049 vs. 0.10 (Mix 25 vs. BHI 30) 3. HYPOGLYCAEMIA: SEVERE DEFINITION: ‐ OUTCOME: ‐ 4. QUALITY OF LIFE: ‐ 5. ADVERSE EVENTS: ‐ 6.COSTS: ‐ 7.DROP OUTS: described 8. OTHERS ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Holcombe 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre, multinational <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> IIT: unclear <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: NORTH AMERICA; AUSTRALIA, EUROPE, South Africa <br> NUMBER: 463 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 15 <br> MEAN DIABETES DURATION [YEARS]: 6 <br> OTHER CHARACTERISTICS: all patients had reached Tanner stage 2 at inclusion </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 120 <br> SCHEDULE: lispro: immediately; regular: 30‐45 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 8.7 vs. 8.7 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3mmol/l and/or symptoms <br> OUTCOME [epis/pat/month]: 4.0 vs. 4.3 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: 6 vs. 5 (lispro vs. regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Holleman 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre, multinational <br> RANDOMISATION PROCEDURE: adequate <br> ALLOCATION CONCEALMENT: adequate <br> BLINDING: open <br> ITT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: UK, Netherlands, Belgium <br> NUMBER: 199 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 35 <br> MEAN DIABETES DURATION [YEARS]: 13 <br> OTHER CHARACTERISTIC: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 84 <br> SCHEDULE: lispro: immediately ; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 7.6 vs. 7.5 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt;3 mmol/l and/or symptoms <br> OUTCOME [overall episodes]: 2249 vs. 2344 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: 36 vs. 58 (lispro vs. regular) <br> 4. QUALITY OF LIFE: <br> 20 questions to rate on a 5 point scales, favouring insulin lispro. <br> 5. ADVERSE EVENTS: <br> 1 person died from ischemic heart disease, no group assignement mentioned <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Home 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: double‐blind <br> ITT: yes <br> SPONOR: Novo Nordisk <br> QUALITY ASSESSMENT:C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: UK <br> NUMBER: 104 <br> TYPE OF DIABETES: 1 <br> AGE MEAN [YEARS]: 34 <br> MEAN DURATION [YEARS]: 15 <br> OTHER CHARACTERISTIC: all participants male </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>ASPART VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 28 <br> SCHEDULE: aspart and regular: immediately </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> ‐ <br> FRUCTOSAMINE [mmol/l]: <br> at endpoint: 3.8 vs. 3.8 (aspart vs. regular) <br> 2. HYPOGLYCAEMIA:OVERALL: <br> DEFINITION: symptoms <br> OUTCOME [overall episodes]: 567 vs. 615 (aspart vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: 20 vs. 44 (aspart vs regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> ‐ <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Home 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: multicentre, multinational <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: Novo Nordisk <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: EUROPE <br> NUMBER: 707 vs. 358 (aspart vs. regular) <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 38 <br> MEAN DIABETES DURATION [YEARS]: 15 <br> OTHER CHARACTERISTICS: ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>ASPART VERSUS REGULAR: <br> LENGTH OF INTERVENTION [days]: 180 <br> SCHEDULE: aspart: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 7.9 vs. 8.0 (aspart vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: symptoms <br> OUTCOME [overall episodes]: 10427 vs. 4474 (aspart vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME[overall episodes]: 314 vs. 152 (aspart vs. regular) <br> 4. QUALITY OF LIFE: <br> at endpoint: DTSQ 32.0 vs. 29.7 (aspart vs regular) <br> 5. ADVERSE EVENTS: <br> 1 death in aspart group (myocardial infarction) <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Iwamoto 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: Novo Nordisk <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Japan <br> NUMBER: 143 vs. 64 (aspart vs. regular) <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 34 vs. 32 (aspart vs. regular) <br> MEAN DIABETES DURATION [YEARS]: 11 <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>ASPART VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 168 <br> SCHEDULE: aspart and regular: previous practice </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 7.4 vs. 7.6 (aspart vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: symptoms <br> OUTCOME [overall episodes]: 550 vs. 261 (aspart vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: ‐ <br> OUTCOME: ‐ <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.FOLLOW UP: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jacobs 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: single centre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: ELi Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Netherlands <br> NUMBER: 12 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 18 <br> MEAN DIABETES DURATION [YEARS]: ‐ <br> OTHER CHARACTERISTICS: including patients from 7 to 34 years of age </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 28 <br> SCHEDULE: lispro: immediately; regular: 15 ‐ 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%] <br> significant improvement in favor of regular during treatment phase <br> 3. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt;3.5 mmol/l and/or symptoms <br> OUTCOME [epis/pat/2 weeks]: 6.5 vs 6.7 (lispro vs.regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes in last 2 weeks]: lispro and regular: 0 <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> not described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Johansson 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: adequate <br> ALLOCATION CONCEALMENT: adequate <br> BLINDING: open <br> ITT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: B </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> NUMBER: 41 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 42 <br> MEAN DIABETES DURATION [YEARS]: 21 <br> OTHER CHARACTERISTICS: patients on CSII therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 60 <br> SCHEDULE: lispro: 5 min.; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 7.4 vs 7.6 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3 mmol/l and/or symptoms <br> OUTCOME [epis/pat/month]: 9.7 vs. 8.0 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME: lispro and regular: 0 <br> 4. QUALITY OF LIFE: <br> WBQ and DTSQ no signifiant difference <br> 5. ADVERSE EVENTS: <br> one episode of ketoacidosis in lispro group due to pump failure <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jovanovic 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: single centre <br> RANDOMIZATION PROCEDURE: adequate <br> ALLOCATION CONCEALMENT: adequate <br> BLINDING: open <br> ITT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: B </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: USA <br> NUMBER: 19 vs. 23 (lispro vs. regular) <br> TYPE OF DIABETES: gestational diabetes <br> MEAN AGE [YEARS]: 34 vs. 30 (lispro vs. regular) <br> MEAN DIABETES DURATION [YEARS]:‐ <br> OTHER CHARACTERISTICS: ethnicity: mainly hispanic, <br> enrollment after dietary therapy failure and exercise failure beginning at gestational week 21, mean enrollment gestational week 27 vs 26 (lispro vs. regular) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION: up to delivery <br> SCHEDULE: lispro: 5 min. ; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> 6 weeks after enrollment: 5.1 vs. 5.2 (lispro vs. regular) <br> 2. HYPOGLYCEMIA: OVERALL <br> DEFINITION: &lt;3.1 mmol <br> OUTCOME: total: no difference <br> 4. HYPOGLYCAEMIA: SEVERE‐ <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: lispro and regular: 0 <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8.OTHERS: <br> no differences in fetal or maternal outcome, no macrosomic newborn in either group, no intrauterine growth restriction, comparable antibody formation to regular insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kotsanos 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover SETTING: multicentre, multinational RANDOMISATION PROCEDURE: unclear ALLOCATION CONCEALMENT: unclear BLINDING: open ITT: unclear SPONSOR: Eli Lilly QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: AMERICA, EUROPE, AUSTRALIA, South Africa <br> NUMBER: Type 1:468; Type 2: 474 <br> TYPE OF DIABETES: 1 and 2 <br> MEAN AGE [YEARS]: Type 1: 34; Type 2: 58 <br> MEAN DIABETES DURATION [YEARS]: Type 1: 13; Type 2: 13 <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR LENGTH OF INTERVENTION [days]: 90 SCHEDULE: analogue: immediately; regular: 30 ‐ 45 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> ‐ <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3.5 mmol/l and/or symptoms <br> OUTCOME: ‐ <br> 3. HYPOGLYCAEMIA : SEVERE <br> DEFINITION: iv glucose or glucagon <br> OUTCOME: ‐ <br> 4. QUALITY OF LIFE: <br> type 1: improvement in 3 of 34 domains of health‐related quality of life in favour of lispro <br> type 2: no significant differences for any domain <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> ‐ <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Quality of life results of a subset of patients of ANDERSON 1997 A and ANDERSON 1997 B </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mecacci 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: single centre <br> RANDOMIZATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: not <br> SPONSOR: not defined <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy NUMBER: 32 vs. 33 (lispro vs. regular) TYPE OF DIABETES: gestational diabetes MEAN AGE [YEARS]: 35 MEAN DIABETES DURATION [YEARS]:‐ OTHER CHARACTERISTICS: ethnicity: caucasian, week of gestation at diagnosis: 28 median, range 25‐32; week of gestation at start of insulin 29, range 27‐32 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR LENGTH OF INTERVENTION: up to delivery SCHEDULE: lispro: immediately; regular: 15 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: at enrollment: 5.5 vs. 5.4; final: 5.2 vs. 5.1(lispro vs. regular) 2. HYPOGLYCEMIA: OVERALL DEFINITION: not reported OUTCOME: not reported 4. HYPOGLYCAEMIA: SEVERE DEFINITION: not reported OUTCOME: not reported 4. QUALITY OF LIFE: ‐ 5. ADVERSE EVENTS: ‐ 6.COSTS: ‐ 7.DROP OUTS: overall 16 (25%) women were lost to follow up: 7 lispro and 9 regular treated: 4 discontinued SBGM, 4 received betamimetics or corticosteroids, five did not deliver at trial center, 3 had a spontanoeus pre‐term delivery 8.OTHERS: no statistically difference between the groups in neonatal outcome and anthropometric characteristics; however, the rate of infants with a cranial‐thoracic circumference (CC/CT) ratio between the 10th and 25th percentile was signifiantly higher in the group treated with regular in a post hoc analyses </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>no differences in fetal or maternal outcomes, no statistical difference in newborn large for gestational age </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Persson 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: multicentre <br> RANDOMIZATION PROCEDURE: adequate <br> ALLOCATION CONCEALMENT: adequate <br> BLINDING: open <br> ITT: yes <br> SPONSOR: not defined <br> QUALITY ASSESSMENT: B </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> NUMBER: 16 vs. 17 (lispro vs. regular) <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 31 vs. 30 (lispro vs. regular) <br> MEAN DIABETES DURATION [YEARS]: 15 vs. 12 (lispro vs. regular) <br> OTHER CHARACTERISTICS: women were recruited at gestational week 6‐8, treated with regular and NPH and were thereafter randomised at week 15 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: until delivery <br> SCHEDULE: lispro: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> last before delivery: 5.2 vs. 5.0 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt;3mmol/l <br> OUTCOME [epis/pat/month]: 1.2 vs. 0.8 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: 0 vs. 4 (lispro vs. regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> Progression of retinopathy in 3/16 and 6/17 patients in lispro and regular group, respectively. <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> not described <br> 8. OTHERS: <br> complications during pregnancy or route of delivery did not differ between the groups, likewise no differences regarding gestational age at delivery, birthweight, rate of LGA infants or neonatal complications, no perinatal deaths or trauma recorded. One malformation, hypospadia, in the regular group. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Provenzano 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: single centre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: not defined <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> NUMBER: 12 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 28 <br> MEAN DIABETES DURATION [YEARS]: 12 <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 168 <br> SCHEDULE: lispro and regular: immediately </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> mean levels for drug treatment: 7.6 vs. 7.8 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: symptoms <br> OUTCOME [overall episodes]: 58 vs. 101 episodes (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: glucagon and/or glucose and/or coma <br> OUTCOME [overall episodes]: 2 vs. 4 (lispro vs. regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7. DROP OUTS: <br> not described <br> 8. OTHERS <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Raskin 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: multicentre, multinational <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: Novo Nordisk <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: NORTH AMERICA <br> NUMBER: 596 vs. 286 (aspart vs. regular) <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 39 vs. 40 (aspart vs. regular) <br> MEAN DIABETES DURATION [YEARS]: 16 <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>ASPART VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 180 <br> SCHEDULE: aspart: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 7.8 vs. 7.9 (aspart vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: 2.5 mmol/l and/or symptoms <br> OUTCOME [epis/pat/year]: 43.4 vs. 45.5 (aspart vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [epis/pat/year]: 0.9 vs. 1.1 (aspart vs. regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Raskin 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: USA <br> NUMBER: 59 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 41 vs. 38 (lispro‐regular vs. regular‐lispro treatment sequence) <br> MEAN DIABETES DURATION [YEARS]: 19 vs.17 (lispro‐regular vs. regular‐lispro treatment sequence) <br> OTHER CHARACTERISTICS: patients on CSII therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 84 <br> SCHEDULE: lispro and regular: immediately </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 7.4 vs. 7.7 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3mmol/l and/or symptoms <br> OUTCOME [overall episodes]: 8 vs. 11 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: iv. glucose <br> OUTCOME [overall episodes]: 3 vs. 3 (lispro vs. regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Recasens 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: single centre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: not defined <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Spain <br> NUMBER: 22 vs. 23 (lispro vs. regular) <br> TYPE OF DIABETES: 1 <br> MEAN AGE [years]: 23 vs. 24 (lispro vs. regular) <br> MEAN DIABETES DURATION [years]: new onset <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 360 <br> SCHEDULE: lispro: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 6.2 vs. 6.3 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &gt; 3.3 mmol/L and/or symptoms <br> OUTCOME: no significant difference <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: lispro and regular: 0 <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7. DROP OUT: <br> not described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Renner 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> NUMBER: 113 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 37 <br> MEAN DIABETES DURATION [YEARS]: 19 <br> OTHER CHARACTERISTICS: patients on CSII therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 120 <br> SCHEDULE: lispro: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 6.8 vs. 6.9 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3.5 mmol/l and/or symptoms <br> OUTCOME [epis/pat/month]: 12.4 vs. 11.0 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: ‐ <br> OUTCOME: ‐ <br> 4. QUALITY OF LIFE: <br> DTSQ‐score significantly improved in lispro group <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> not decribed <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Roach 1999a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre, multinational <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> IIT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany, Hungary, Netherlands, Switzerland, UK <br> NUMBER: Type 1: 37; Type 2: 63 <br> TYPE OF DIABETES: 1 and 2 <br> MEAN AGE [YEARS]: Type 1: 42 vs. 37; Type 2: 58 vs. 60 (premixed formuation of lispro Mix 25 at breakfast and Mix 50 at dinner [Mix 25/ Mix 50] ‐ premixed formulation of regular insulin BHI 50 and BHI 30 [BHI 50/BHI 30] sequence vs. BHI 50/BHI 30 ‐ Mix 50/Mix 25 ‐sequence <br> MEAN DIABETES DURATION [YEARS]: Type 1: 14 vs. 11; Type 2: 12 vs. 13 (Mix 50/Mix 25‐BHI 50/ BHI25 vs. BHI 50/BHI 30 ‐ Mix 50/Mix 25) <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Mix 50/Mix 25 VERSUS‐ <br> BHI 50/ BHI 30 <br> LENGTH OF INTERVENTION [days]: 90 <br> SCHEDULE: Mix 50/Mix 25: immediately; BHI 50/BHI 30: 30 to 45 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: Type 1: 7.7 vs. 7.4; <br> Type 2: 7.7 vs. 7.7 (Mix 50/Mix25 vs. BHI 50/BHI25) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3 mmol/l and/or symptoms <br> OUTCOME: Type 1 and 2: no significant difference (Mix 50/Mix25 vs. BHI 50/BHI25) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: coma and/or glucagon and/or glucose <br> OUTCOME [overall episodes]: Type : 2 vs. 4 (Mix 50/Mix25 vs. BHI 50/BHI25) <br> Type 2: not reported <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Roach 1999b </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre, multinational <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Spain, South Africa, UK <br> NUMBER: 89 <br> TYPE OF DIABETES: 2 <br> MEAN AGE [YEARS]: 57 <br> MEAN DIABETES DURATION [YEARS]: ˜ 12‐13 <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Mixture of 25%Lispro (Mix25) VERSUS mixture of regular (BHI 30) <br> LENGTH OF INTERVENTION [days]: 90 <br> SCHEDULE: Mix 25: immediately; BHI 30: 20‐30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 7.8 vs. 8.1 ( Mix 25 vs. BHI 30) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3 mmol/l and/or symptoms <br> OUTCOME: no significant difference <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [pat]: 1 vs. 1 (Mix 25 vs. BHI 30) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ross 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: parallel <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: yes <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada <br> NUMBER: 70 vs. 78 (lispro vs. regular) <br> TYPE OF DIABETES: 2 <br> MEAN AGE [YEARS]: 59 vs. 58 (lispro vs. regular) <br> MEAN DIABETES DURATION [YEARS]: 11 <br> OTHER CHARACTERISTICS: patients with maximum doses of oral agents (sulphonyurea or metformin) without achieving acceptable control </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 165 <br> SCHEDULE: lispro: immediately ; regular: 30‐45 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 8.0 vs. 8.0 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3mmol/l and/or symptoms <br> OUTCOME [epis/pat/month]: 1.8 vs. 1.7 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME: not reported <br> 4. QUALITY OF LIFE: <br> no overall improvment in DQOL score in 49 patients in lispro group and 53 patients of regular group, who completed questionaire <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS <br> ‐ <br> 7. DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Schmauss 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: single centre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> NUMBER: 11 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 30 <br> MEAN DIABETES DURATION [YEARS]: 14 <br> OTHER CHARACTERISTICS: patients on CSII therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR: <br> LENGTH OF INTERVENTION [days]: 90 <br> SCHEDULE: lispro: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> no significant difference <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3.5 mmol/l and/or symptoms <br> OUTCOME [epis/pat/month]: 4 vs. 3.2 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: glucagon and/or glucose <br> OUTCOME [overall episodes]: lispro and regular: 0 <br> 4. QUALITY OF LIFE: <br> "no significant difference concerning treatment satisfation", no scores/methods shown <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Skrha 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover SETTING: multicentre, multinational RANDOMISATION PROCEDURE: unclear ALLOCATION CONCEALMENT: unclear BLINDING: open ITT: unclear SPONSOR: Eli Lilly QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Czech Republic, Slovenia, Slovak Republic NUMBER: Type 1: 55; Type 2: 7; TYPE OF DIABETES: 1 and 2 MEAN AGE [YEARS]: Type 1 and Type 2: 36 MEAN DIABETES DURATION [YEARS]: Type 1 and Type 2: 11 OTHER CHARACTERISTICS:‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR: LENGTH OF INTERVENTION [days]: 60 SCHEDULE: lispro: immediately; regular: 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: Type 1 and Type 2: 7.6 vs. 7.4 (lispro vs. regular) 2. HYPOGLYCAEMIA: OVERALL DEFINITION: &lt; 3.5 mmol/l and/or symptoms OUTCOME [percent of patients]: 66 vs. 63 (lispro vs. regular) 3. HYPOGLYCAEMIA: SEVERE DEFINITION: not defined OUTCOME: not reported 4. QUALITY OF LIFE: ‐ 5. ADVERSE EVENTS: ‐ 6.COSTS: ‐ 7.DROP OUTS: not described 8. OTHERS: ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Tubiana‐Rufi 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover SETTING: multicentre RANDOMISATION PROCEDURE: unclear ALLOCATION CONCEALMENT: unclear BLINDING: open ITT: no <br> SPONSOR: Eli Lilly QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: France <br> NUMBER: 29 <br> TYPE OF DIABETES: 1 MEAN AGE [YEARS]: 5 <br> MEAN DIABETES DURATION [YEARS]: ‐ OTHER CHARACTERISTICS:‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR: LENGTH OF INTERVENTION [days]: 112 SCHEDULE: lispro: immediately; regular: 20‐30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> changes at end of first study period <br> 0.2 vs. 0.1 (lispro vs. regular) <br> 2. HYPOGLYCEMIA: OVERALL <br> DEFINITION: <br> OUTCOME [epis/pat/month]: 4.9 vs. 4.4 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: unconsciousness <br> OUTCOME [overall episodes]: 2 vs. 2 (lispro vs. regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Tupola 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: adequate <br> ALLOCATION CONCEALMENT: adequate <br> BLINDING: open <br> ITT: unclear <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: B </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: France <br> NUMBER: 29 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 6 <br> MEAN DIABETES DURATION [YEARS]: 3 <br> OTHER CHARACTERISTICS: all participants were prepubertal before and at the end of study </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 90 <br> SCHEDULE: lispro: no longer than 30 min. from the start of the meal; regular: 20 ‐ 30 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> no significant difference <br> 2. HYPOGLYCEMIA: OVERALL <br> DEFINITION: &lt;3.3 mmol/l <br> OUTCOME [ep/pat/within LAST 30 days]: 14 vs. 11 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: ‐ <br> OUTCOME‐ <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: ketoacidosis: 0 vs. 2 (lispro vs. regular) <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8. OTHERS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c analysis: only first treatment period due to carry‐over effect</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Vignati 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre, multinational <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: open <br> ITT: no <br> SPONSOR: Eli Lilly <br> ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: USA ,Canada, EUROPE, AUSTRALIA, South Africa <br> NUMBER: Type 1: 379; Type 2: 328 <br> TYPE OF DIABETES: Type 1 and 2 <br> MEAN AGE [YEARS]: Type 1:39; Type 2: 58 <br> MEAN DIABETES DURATION [YEARS]: Type 1:13; Type 2: 13 <br> OTHER CHARACTERISTICS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 60 <br> SCHEDULE: lispro: immediately; regular: previous practice </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: Type 1: 7.8 vs. 7.9; Type 2: 8.1 vs. 8.1 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3.5 mmol/l <br> OUTCOME [epis/pat/month]: Type 1: 4.6 vs. 4.5; Type 2: 1.9 vs. 1.9 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: glucagon <br> OUTCOME [pat]: Type 1: 5 vs. 5; Type 2: 0 vs. 0 (lispro vs. regular) <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7. DROP OUTS: <br> described <br> 8. OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Zinman 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover <br> SETTING: multicentre <br> RANDOMISATION PROCEDURE: unclear <br> ALLOCATION CONCEALMENT: unclear <br> BLINDING: double‐blind <br> ITT: unclear <br> SPONSOR: Eli Lilly <br> QUALITY ASSESSMENT: C </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: CANADA <br> NUMBER: 30 <br> TYPE OF DIABETES: 1 <br> MEAN AGE [YEARS]: 35 <br> MEAN DIABETES DURATION [YEARS]: 18 <br> OTHER CHARACTERISTICS: patients on CSII therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>LISPRO VERSUS REGULAR <br> LENGTH OF INTERVENTION [days]: 90 <br> SCHEDULE: lispro and regular: immediately: 0‐5 min. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1.HBA1C [%]: <br> at endpoint: 7.7 vs. 8.0 (lispro vs. regular) <br> 2. HYPOGLYCAEMIA: OVERALL <br> DEFINITION: &lt; 3mmol and/or symptoms <br> OUTCOME [epis/pat/month]: 8.6 vs. 10.8 (lispro vs. regular) <br> 3. HYPOGLYCAEMIA: SEVERE <br> DEFINITION: third party help <br> OUTCOME [overall episodes]: lispro and regular: 0 <br> 4. QUALITY OF LIFE: <br> ‐ <br> 5. ADVERSE EVENTS: <br> ‐ <br> 6.COSTS: <br> ‐ <br> 7.DROP OUTS: <br> described <br> 8.OTHERS: <br> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD003287-sec2-0017"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD003287-sec2-0016" class="jump-to">included studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0050">Bastyr 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no information according to our predefined endpoints</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0051">Boehm 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not randomised</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0052">Colombel 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no comparable insulin regimen in intervention and control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0053">Cypryk 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not randomised</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0054">DeVries 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no comparable insulin regimen in intervention and control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0055">Fineberg 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Did not provide any additional information according to our predefined endpoints</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0056">Garg 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>including new onset type 1 diabetic patients, receiving different insulin regimen, with unclear group assignment. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0057">Garg 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not randomised</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0058">Heller 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Substudy of Heller 1999, did not provide any additional information according to our predefined endpoints </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0059">Herz 2002b</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no comparable insulin regimen in intervention and control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0060">Janssen 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no comparable insulin regimen in intervention and control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0061">Jansson 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no comparable insulin regimen in intervention and control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0062">Kaplan 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No comparison between analogues and regular</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0063">Kaufman 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no comparable insulin regimen in intervention and control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0064">Kilo 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Included patients receiving oral antidiabetic agents</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0065">Krzymien 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>duration of intervention less than 4 weeks</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0066">Lalli 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no comparable insulin regimen in intervention and control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0067">Laube 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>duplicate publishing, substudy from multicentre trial (not referenced)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0068">Loba 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>non randomised</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0069">Martin 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no comparable insulin regimen in intervention and control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0070">McSorley 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>duration of intervention less than 4 weeks</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0071">Melki 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>results for only the first period of treatment available.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0072">Nielsen 1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>insulin not available on market</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0073">Petersen 1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>duplicate publishing, substudy from multicentre trial (not referenced)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0074">Pfuetzner 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>duplicate publishing, substudy from multicentre trial (Anderson 1997 B)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0075">Roach 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no comparable insulin regimen in intervention and control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0076">Sargin 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no comparable insulin regimen in intervention and control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0077">Schernthaner 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>no comparable insulin regimen in intervention and control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0078">Tamas 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>only preliminary results (week 12 of 64) shown</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0079">Tsui 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Substudy of Zinman 1997, did not provide any additional information according to our predefined endpoints </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD003287-bbs2-0080">Velussi 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not randomised</p> </td> </tr> </tbody> </table> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD003287-sec1-0010"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD003287-tbl-0001"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Hba1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.16, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD003287-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-01.png?filename=nCD003287-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%201%20Hba1c.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD003287-fig-00101" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-01.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 1 Hba1c."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 1 Hba1c. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Hba1c by different types of interventions: CSII,. IIT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.16, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD003287-fig-00102"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-02.png?filename=nCD003287-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%202%20Hba1c%20by%20different%20types%20of%20interventions%3A%20CSII%2C.%20IIT.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.2</div> </div> <hr class="top"><img data-id="CD003287-fig-00102" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-02.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 2 Hba1c by different types of interventions: CSII,. IIT."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 2 Hba1c by different types of interventions: CSII,. IIT. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 CSII</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.20 [‐0.27, ‐0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 IIT</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.06 [‐0.12, ‐0.00]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Hba1c by duration of study: less than or equal to 3 months, more than 3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.16, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD003287-fig-00103"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-03.png?filename=nCD003287-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%203%20Hba1c%20by%20duration%20of%20study%3A%20less%20than%20or%20equal%20to%203%20months%2C%20more%20than%203%20months.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.3</div> </div> <hr class="top"><img data-id="CD003287-fig-00103" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-03.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 3 Hba1c by duration of study: less than or equal to 3 months, more than 3 months."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 3 Hba1c by duration of study: less than or equal to 3 months, more than 3 months. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 &lt;= 3 months</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.16, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 &gt;3 months</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.12 [‐0.17, ‐0.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Hba1c by different short acting insulin analogues: Lispro, Aspart <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>21</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.16, ‐0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD003287-fig-00104"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-04.png?filename=nCD003287-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%204%20Hba1c%20by%20different%20short%20acting%20insulin%20analogues%3A%20Lispro%2C%20Aspart.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.4</div> </div> <hr class="top"><img data-id="CD003287-fig-00104" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-04.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 4 Hba1c by different short acting insulin analogues: Lispro, Aspart."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 4 Hba1c by different short acting insulin analogues: Lispro, Aspart. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Lispro</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.18, ‐0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Aspart</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.19, ‐0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Hba1c by different types of study design: parallel, cross‐over studies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.16, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD003287-fig-00105"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-05.png?filename=nCD003287-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%205%20Hba1c%20by%20different%20types%20of%20study%20design%3A%20parallel%2C%20cross%E2%80%90over%20studies.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.5</div> </div> <hr class="top"><img data-id="CD003287-fig-00105" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-05.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 5 Hba1c by different types of study design: parallel, cross‐over studies."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 5 Hba1c by different types of study design: parallel, cross‐over studies. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 parallel studies</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.20, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 cross‐over studies</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>26</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.17, ‐0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Hypoglycaemic episodes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4266</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.23 [‐1.14, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD003287-fig-00106"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-06.png?filename=nCD003287-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%206%20Hypoglycaemic%20episodes.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.6</div> </div> <hr class="top"><img data-id="CD003287-fig-00106" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-06.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 6 Hypoglycaemic episodes."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 6 Hypoglycaemic episodes. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD003287-tbl-0002"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Type 2 diabetic patients: short acting insulin analogues versus structurally unchanged insulin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Hba1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.03 [‐0.11, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD003287-fig-00201"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-002-01.png?filename=nCD003287-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Type%202%20diabetic%20patients%3A%20short%20acting%20insulin%20analogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%201%20Hba1c.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.1</div> </div> <hr class="top"><img data-id="CD003287-fig-00201" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-002-01.png" alt="Comparison 2 Type 2 diabetic patients: short acting insulin analogues versus structurally unchanged insulin, Outcome 1 Hba1c."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Type 2 diabetic patients: short acting insulin analogues versus structurally unchanged insulin, Outcome 1 Hba1c. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Hypoglycaemic episodes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2617</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.46, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD003287-fig-00202"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-002-02.png?filename=nCD003287-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Type%202%20diabetic%20patients%3A%20short%20acting%20insulin%20analogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%202%20Hypoglycaemic%20episodes.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.2</div> </div> <hr class="top"><img data-id="CD003287-fig-00202" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-002-02.png" alt="Comparison 2 Type 2 diabetic patients: short acting insulin analogues versus structurally unchanged insulin, Outcome 2 Hypoglycaemic episodes."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Type 2 diabetic patients: short acting insulin analogues versus structurally unchanged insulin, Outcome 2 Hypoglycaemic episodes. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD003287-fig-0001"> <img data-id="CD003287-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-AFig-FIG01.png" alt="Copyright©2006(Siebenhofer: reproduced with permission)"> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Copyright©2006(Siebenhofer: reproduced with permission)</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/full#CD003287-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-AFig-FIG01.png?filename=nCD003287-AFig-FIG01.ppt&amp;title=1&amp;caption=Copyright%C2%A92006%28Siebenhofer%3A%20reproduced%20with%20permission%29&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD003287-fig-00101"><img data-id="CD003287-fig-00101" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-01.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 1 Hba1c."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 1 Hba1c. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#CD003287-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-01.png?filename=nCD003287-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%201%20Hba1c.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD003287-fig-00102"><img data-id="CD003287-fig-00102" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-02.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 2 Hba1c by different types of interventions: CSII,. IIT."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 2 Hba1c by different types of interventions: CSII,. IIT. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#CD003287-fig-00102" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-02.png?filename=nCD003287-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%202%20Hba1c%20by%20different%20types%20of%20interventions%3A%20CSII%2C.%20IIT.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD003287-fig-00103"><img data-id="CD003287-fig-00103" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-03.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 3 Hba1c by duration of study: less than or equal to 3 months, more than 3 months."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 3 Hba1c by duration of study: less than or equal to 3 months, more than 3 months. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#CD003287-fig-00103" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-03.png?filename=nCD003287-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%203%20Hba1c%20by%20duration%20of%20study%3A%20less%20than%20or%20equal%20to%203%20months%2C%20more%20than%203%20months.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD003287-fig-00104"><img data-id="CD003287-fig-00104" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-04.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 4 Hba1c by different short acting insulin analogues: Lispro, Aspart."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 4 Hba1c by different short acting insulin analogues: Lispro, Aspart. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#CD003287-fig-00104" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-04.png?filename=nCD003287-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%204%20Hba1c%20by%20different%20short%20acting%20insulin%20analogues%3A%20Lispro%2C%20Aspart.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD003287-fig-00105"><img data-id="CD003287-fig-00105" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-05.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 5 Hba1c by different types of study design: parallel, cross‐over studies."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 5 Hba1c by different types of study design: parallel, cross‐over studies. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#CD003287-fig-00105" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-05.png?filename=nCD003287-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%205%20Hba1c%20by%20different%20types%20of%20study%20design%3A%20parallel%2C%20cross%E2%80%90over%20studies.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD003287-fig-00106"><img data-id="CD003287-fig-00106" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-06.png" alt="Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 6 Hypoglycaemic episodes."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin, Outcome 6 Hypoglycaemic episodes. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#CD003287-fig-00106" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-001-06.png?filename=nCD003287-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20Type%201%20diabetic%20patients%3A%20short%20acting%20insulin%20anlogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%206%20Hypoglycaemic%20episodes.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-001-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD003287-fig-00201"><img data-id="CD003287-fig-00201" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-002-01.png" alt="Comparison 2 Type 2 diabetic patients: short acting insulin analogues versus structurally unchanged insulin, Outcome 1 Hba1c."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Type 2 diabetic patients: short acting insulin analogues versus structurally unchanged insulin, Outcome 1 Hba1c. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#CD003287-fig-00201" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-002-01.png?filename=nCD003287-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Type%202%20diabetic%20patients%3A%20short%20acting%20insulin%20analogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%201%20Hba1c.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-002-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD003287-fig-00202"><img data-id="CD003287-fig-00202" src="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-002-02.png" alt="Comparison 2 Type 2 diabetic patients: short acting insulin analogues versus structurally unchanged insulin, Outcome 2 Hypoglycaemic episodes."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Type 2 diabetic patients: short acting insulin analogues versus structurally unchanged insulin, Outcome 2 Hypoglycaemic episodes. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#CD003287-fig-00202" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/ppt/CDSR/CD003287/image_n/nCD003287-CMP-002-02.png?filename=nCD003287-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Type%202%20diabetic%20patients%3A%20short%20acting%20insulin%20analogues%20versus%20structurally%20unchanged%20insulin%2C%20Outcome%202%20Hypoglycaemic%20episodes.&amp;citation=Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, 2. Art. No.: CD003287. DOI: http://dx.doi.org/10.1002/14651858.CD003287.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD003287.pub4/media/CDSR/CD003287/image_n/nCD003287-CMP-002-02.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD003287-tbl-0001" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Hba1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.16, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Hba1c by different types of interventions: CSII,. IIT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.16, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 CSII</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.20 [‐0.27, ‐0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 IIT</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.06 [‐0.12, ‐0.00]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Hba1c by duration of study: less than or equal to 3 months, more than 3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.16, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 &lt;= 3 months</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.16, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 &gt;3 months</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.12 [‐0.17, ‐0.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Hba1c by different short acting insulin analogues: Lispro, Aspart <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>21</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.16, ‐0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Lispro</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.18, ‐0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Aspart</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.19, ‐0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Hba1c by different types of study design: parallel, cross‐over studies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.16, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 parallel studies</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.20, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 cross‐over studies</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>26</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.17, ‐0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Hypoglycaemic episodes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4266</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.23 [‐1.14, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Type 1 diabetic patients: short acting insulin anlogues versus structurally unchanged insulin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#CD003287-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD003287-tbl-0002" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Type 2 diabetic patients: short acting insulin analogues versus structurally unchanged insulin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Hba1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mean difference (Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.03 [‐0.11, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Hypoglycaemic episodes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2617</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.46, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Type 2 diabetic patients: short acting insulin analogues versus structurally unchanged insulin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD003287.pub4/references#CD003287-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD003287-note-1203">Español</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1581423095000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581423095000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717777000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717709000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717714000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003287\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003287\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003287\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003287\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003287\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581423095000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003287.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003287.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD003287.pub4/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD003287.pub4/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003287.pub4%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583239515543" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583239515547" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD003287&#x2e;pub4&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD003287.pub4";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 